CN220043735U

CN220043735U - Apparatus for generating cold air plasma and apparatus for generating corona cold air plasma

Info

Publication number: CN220043735U
Application number: CN202220754681.0U
Authority: CN
Inventors: 戴博拉·路易丝·布莱克
Original assignee: North Australia Liker Intellectual Property Private Ltd
Current assignee: North Australia Liker Intellectual Property Private Ltd
Priority date: 2021-06-18
Filing date: 2022-03-31
Publication date: 2023-11-17
Anticipated expiration: 2032-03-31

Abstract

An apparatus for generating a cold air plasma, the apparatus comprising: a housing including a plurality of spaced apart openings; a plurality of needles, each needle positioned in a respective opening; and a driving circuit that generates an electrical signal applied to the needle to generate a pulsed electromagnetic field (PEMF), wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency, thereby generating a cold air plasma.

Description

Apparatus for generating cold air plasma and apparatus for generating corona cold air plasma

Technical Field

The present utility model relates to a method for generating Cold Air Plasma (CAP) reactive air speciesOptionally having a negative polarity and/or a neutral polarity, and optionally generating hydrogen (H) ₂ ) And optionally generated using a pulsed electromagnetic field (PEMF) from ambient air temperature and unbalanced atmospheric air pressure.

Background

The reference in this specification to any prior publication (or to any matter which is derived from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or admission or any form of suggestion that the prior publication (or to any of its derived information) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.

It is well known that small negatively charged air ions are bioactive and over time, can improve health results by taking in negative ions. It is known to provide ionization devices capable of producing such negatively charged ions.

US 5,973,905 describes a negative ion generator having a plurality of needle assemblies, each of which has a different needle end point. The generator comprises a drive circuit for supplying a high voltage to the needle terminals and a selection circuit by means of which the amount and/or frequency of ions generated is selected. The needle assembly can be replaced by a user with a plug and socket type connection. Indication means are provided for indicating to a user of the generator the condition of the needle assembly and when the needle should be replaced. The drive circuit may include a safe current path in the event of a ground fault.

Disclosure of Invention

In one broad form, one aspect of the utility model seeks to provide an apparatus for generating a cold air plasma, the apparatus comprising: a housing including a plurality of spaced apart openings; a plurality of needles, each needle positioned in a respective opening; a drive circuit that generates an electrical signal that is applied to the needle to generate a pulsed electromagnetic field (PEMF), wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency to generate a cold air plasma.

In one embodiment, the electrical signal and PEMF have varying frequencies, intensities, and a variety of waveforms, including at least one of the following: a non-square waveform; a right-angle waveform; square wave shape; a sinusoidal waveform; a triangular waveform; a composite waveform; fourier modifying the waveform; a zigzag waveform; wave grain bistrunk; and, a shark tooth waveform.

In one embodiment, the carrier frequency is at least one of: in the range of 17kHz to 18 kHz; in the range of 17.25kHz to 17.75 kHz; in the range of 17.4kHz to 17.6 kHz; and about 17.5kHz + -0.25%.

In one embodiment, the pulse frequency is at least one of: in the range of 0.1Hz to 40 Hz; in the range of 0.1Hz to 4Hz; less than 1Hz; about 4Hz; about 7.83Hz; about 8Hz; about 10Hz; about 16Hz; about 25Hz; about 32Hz; about 40Hz.

In one embodiment, the device includes a user input that allows for selection of the pulse frequency and intensity.

In one embodiment, a driving circuit includes: a rectifier configured to be attachable to a mains power supply; a switch mode power supply coupled to the rectifier; a pulse transformer coupled to the switched mode power supply; and a voltage multiplier connecting the pulse transformer to the pin.

In one embodiment, the pulse transformer is one of the following: configured to produce an output voltage of approximately 3500-4500 volts; and, include 178: a turns ratio of 1.

In one embodiment, the voltage multiplier is configured to produce an output voltage of about 17500 volts.

In one embodiment, the electrical signal at the tip of the needle has a voltage that meets at least one of the following conditions: greater than 12000 volts; in the range of 12000 volts to 14000 volts; in the range 12500 volts to 13500 volts; about 13000 volts ± 0.25%.

In one embodiment, the power circuit includes a bridge resistor arrangement that bridges the AC adapter transformer.

In one embodiment, the bridge resistor means provides a ground reference via the neutral line of the ac mains power supply.

In one embodiment, the bridge resistor arrangement includes at least two resistors that provide two operator protection devices and a return path for charged electrons from the circuit.

In one embodiment, the apparatus is configured to provide a return current path, allowing electrons stripped from molecules and/or ions to return via the treatment object.

In one embodiment, the apparatus includes an insulating member surrounding the high voltage assembly.

In one embodiment, the insulating member has at least one of the following features: has a curled shape; and providing a current flow path to the needle.

In one embodiment, the apparatus comprises an ac adapter configured to be attachable to an alternating mains power supply.

In one embodiment, the ac adapter includes a barrel plug connected to a barrel socket in the housing, and wherein the barrel socket is recessed into the housing to reduce static electricity accumulation.

In one embodiment, the ac adapter comprises a pulse transformer.

In one embodiment, the apparatus is configured to be able to generate corona cold air plasma and other quantum air species having negative or neutral polarity inside a plasma plume (also known as a plume) at and/or at the tip of the needle or in a plume space (volume space) of less than about 3mm outside the tip of the needle.

In one embodiment, the apparatus includes a plurality of gold plated needle assemblies in electrical contact with the voltage multiplier, each needle assembly configured to receive a respective needle.

In one embodiment, a needle comprises: a shaft configured to be attachable to a needle assembly within the housing; and a tip protruding into the opening, the opening being a hollow semicircular opening.

In one embodiment, the length of the shaft is about 60% of the length of the needle.

In one embodiment, the needle is made from a combination of multiple metals.

In one embodiment, the device comprises up to eight needles circumferentially spaced around the circular housing, and wherein every fourth set of needles are equally spaced from each other.

In one embodiment, the device includes one or more caps configured to be positionable in the opening to selectively deactivate the one or more needles.

In one embodiment, the device is configured to be capable of and/or cause the production of at least one of: reactive nitroxides (clusters or materials) (RONS for short) and/or their inverse particles; a complex mixture of RONS and/or their inverse particles; reactive oxygen species (clusters or species) (ROS for short) and/or their counter-particles; singlet oxygen, superoxide and/or their related and counter particles; electrons (light), positrons, atoms, and photons; muons, pi-mesons, protons, anti-protons (quack's hadrons), neutrinos, anti-neutrinos, wavelets biennial, neutral quantum elements and quantum particles; force field energy quantum particles and waves; ruach energy; ruach vitality; dark energy; a counter substance; other quantum air species and quantum energy fields; REDOX effects on and in the body (REDOX effects); and electroporation and/or plasma perforation on the skin.

In one embodiment, the apparatus is configured to be capable of generating a cold air species having at least one of the following ion densities: over 900000 ions per cubic centimeter at one meter from the apparatus; at 300mm from the device, more than 990 ten thousand per cubic centimeter (9.9X10) ⁶ ) An ion; at a distance of 100mm from the apparatus, more than 2800 ten thousand per cubic centimeter (28×10) ⁶ ) An ion; and, at 50mm from the device, more than 3000 ten thousand per cubic centimeter (30×10) ⁶ ) And (3) ions.

In one embodiment, the apparatus is configured to generate cold air species having an ozone concentration of less than 0.04 ppm.

In one embodiment, the device is configured to be capable of generatingAn air species having at least one of the following flow rates: at 300mm from the device, more than 40.3 trillion per second (40.3 x 10) ¹² ) An ion; at 100mm from the instrument, more than 50.1 trillion ions per second (50.1X10 ¹² ) The method comprises the steps of carrying out a first treatment on the surface of the And, at 50mm from the instrument, over 76.8 trillion ions per second (76.8X10 ¹² )。

In one embodiment, the device is configured to be capable of at least one of: generating a pulsed electromagnetic field; generating ions in the air adjacent to the housing; generating into the air in the vicinity of the housing various air species including electrons and ions that are at a high spin atomic temperature but cold to the touch; generating various wave grain biennial air species including electrons and ions; transporting ions away from the housing; delivering various air species including electrons and ions away from the housing to the air delivery pathway and into or onto the human body; creating an environment in which the PEMF collides with the magnetic field at right angles to generate cold fusion discharge and optical energy photons within the body; changing the field by collision of the circuit such that it points in a second direction again perpendicular to the device; generating a biosafety discharge from cold fusion and generating photons of light energy, muons and pi-muons in the body; generating biosafety electrical discharge and photon energy inside the body, resulting in water electrolysis, hydrogen H in body chemistry ₂ The method comprises the steps of carrying out a first treatment on the surface of the Leaving the charged molecules in the body while the current and magnetic flow strip electrons and/or mesogens from the molecules and then move them out of the body; leaving the charged molecules in the body, while electrons and neutropes quantum tunneled out of the body, out of the molecules and back into the circuit; pulling various air species including electrons and/or neutrinos back into the circuit and then to ground established within the housing; pulling the electrons to ground and back into the device where they return to the needle and become secondary electrons (secondary electrons) that retain memory of their previous energy and are therefore more energetic than before being placed back into the treatment object; and, repeatedly passing the process through the circuit at a magnetic speed approaching the speed of light.

In one embodiment, the device is configured to provide selective whole body adaptogen (Selective Systemic Adaptogen) therapy to the subject and response from the subject's body and/or create an environment for dynamic balance to occur within the subject.

In one embodiment, the apparatus inactivates the virus by damaging the capsid to surround and inactivate the capsid using mechanical vibration of an air species, resulting in inactivation of its contents.

In one embodiment, at least one of the following is performed: resonance is generated in the fluid system of the body after being stimulated by the Ruach vital force field, generated by cold fusion collisions of fields within the circuit and stripping electrons from photon-generating ions at magnetic speeds approaching the speed of light, by receiving the electrical conductivity of the subject vibrating by atomic heat, spin and RONS and other quantum air species; and, by receiving the electrical conductivity of the subject of atomic heat, spin and negative oxygen ion-containing vibration from the CAP, combining with photons generated at magnetic velocity from the resonance frequency of air species in the body system, wherein these photons are carried with the flow of fluid protected by water molecules throughout the human body prior to internal hydrolytic stimulation, called Ruach viability, generated within the subject.

In one embodiment, the device output frequency shape is designed to mimic the geometry of SARS-CoV-2 virus for disruption and inactivation of viral geometry and physical communication to achieve immunomodulation in an congenital treatment subject.

In one embodiment, the cold air gas plasma generates RONS and/or other air species that transfer reactivity into the fluid of the respiratory mucosal system to induce further biochemical reactions and pathogen inactivation through intracellular and intercellular water-memorized plasma and biological field communication.

In one embodiment, the conductivity in the subject is determined by the ion-containing negative oxygen rather than by electrons, which are stripped from the ions leaving molecules within the subject, while the electrons return to the circuit to obtain ground potential.

In one embodiment, in use, the subject is positioned in a recommended manner appropriate for at least one of the following treatment conditions: in the range of 15cm to 1m from the housing; about 1m from the housing; a distance from the housing in the range of 1 meter to 2 meters; and in a room where the device is installed.

In one embodiment, the device is configured to be capable of driving air species and PEMFs and resonances into the respiratory system and/or skin and/or orifice of a subject at least in part through a common ground connection with the subject.

In one embodiment, the device is configured to create a balanced and dynamically balanced environment through a combination of CAP, RONS, PEMF and energy vitality to restore molecular aging and cytopathogenesis.

In one embodiment, the cold air plasma and energy field reduce the effects of hormonal system abscisic acid, which reduces the accumulation and potential of oncogenic stress, gene expression of chromatin tissues and senescent cells, and by doing so protects humans from biological aging and reduces progressive deterioration of functional features in aging disease.

In one embodiment, the device is configured to be capable of at least one of: providing a systemic selective adaptive pro-response; causing apoptosis; interactions occur as retrograde transport along the nerves of the entire body, in particular the vagus nerve; through the blood-brain barrier into the central nervous system; interact with the central nervous system to induce systemic innate immunity and adaptive immune responses; inducing an immune response by interacting with at least one of: serotonin; melatonin; mitochondria; hydrogen, hydrogen peroxide and/or hydroxyl radicals, lycopene; glutathione, hormonal systems, and all body systems.

In one embodiment, the device is configured to treat and prevent any one or a combination of the following as a whole body selective adaptogen solution: respiratory diseases; asthma and bronchitis; chronic Obstructive Pulmonary Disease (COPD); emphysema; absence of smell; silicosis, a lung disease; lung disease; black lung disease; SARS-CoV-2 (COVID-19), including all variations; common cold and influenza, including all mutations; all viral, bacterial, fungal and other pathogen infections and mutations; long-term symptoms and infections of all viruses, bacteria, fungi and other pathogens; sleep apnea; cancer; basal cell carcinoma; breast cancer; glioblastoma; brain cancer; lung cancer; bladder cancer; endometrial cancer; metastatic cancer; modulating inflammation; stimulating a selective systemic regulatory immune response; diabetes mellitus; depression and post-traumatic stress disorder; anti-aging; alzheimer's disease and vascular dementia; lowering blood pressure; skin diseases; psoriasis; eczema; dermatitis is treated; a diabetic foot wound; a surgical wound; burns and scars; autoimmune diseases; lupus; hashimoto's disease; transverse myelitis; fibromyalgia; diabetes mellitus; lyme disease; ross river fever; brain fog; and all allergies.

In one broad form, one aspect of the utility model seeks to provide a method of providing therapy to a subject, the method comprising generating a cold air plasma with an apparatus comprising: a housing including a plurality of spaced apart openings; a plurality of needles, each needle positioned in a respective opening; and a driving circuit that generates an electrical signal applied to the needle to generate a pulsed electromagnetic field, wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency, thereby generating a cold air plasma.

In one broad form, one aspect of the utility model seeks to provide an apparatus for generating a corona cold air plasma, the apparatus comprising: a housing including a plurality of spaced apart openings; a plurality of needles, each needle positioned in a respective opening; a drive circuit that generates an electrical signal applied to the needle to generate a pulsed electromagnetic field (PEMF), wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency to generate a corona cold air plasma RONS and other quantum species of negative and neutral polarity excited by Ruach viability, and wherein the apparatus induces a whole body selective adaptive reaction within the subject when the subject is exposed to the generated corona cold air plasma.

In one embodiment, the systemic selective adaptogen responseIs produced by Ruach life force field energy and subsequent use thereof for hydrogen production (H ₂ ) Is induced and excited by water electrolysis.

It should be understood that the broad forms of the utility model and their respective features can be used in combination and/or independently and reference to separate broad forms is not intended to limit the scope. Furthermore, it will be appreciated that the features of the method may be performed using the system or apparatus, and the features of the system or apparatus may be implemented using the method.

Drawings

Various examples and embodiments of the utility model will now be described with reference to the accompanying drawings, in which:

fig. 1 and 2 are rear and front views showing examples of the negative ion generator;

FIG. 3 is a cut-away perspective view showing a needle assembly for the negative ion generator device of FIG. 1;

fig. 4 is an enlarged view of a second terminal connector device as part of the assembly of fig. 3;

FIG. 5 is a schematic block diagram of the negative ion generator of FIG. 1;

FIG. 6 is a schematic diagram illustrating control and operating current of the negative ion generator of FIG. 1;

FIG. 7 is a schematic diagram showing a voltage multiplier circuit used by the negative ion generator of FIG. 1;

FIG. 8 is an exemplary drive circuit for the negative ion generator of FIG. 1;

fig. 9 is a schematic diagram of an example of a power supply circuit of an apparatus for generating cold air plasma;

FIGS. 10A and 10B are images of basal cell carcinoma behind the right ear of a pre-treatment patient;

FIGS. 10C and 10D are images of the basal cell carcinoma of FIGS. 10A and 10B after treatment using a cold air plasma generating device; the method comprises the steps of,

figures 11A to 11D are images of heel pulseless (heel necrosis) under treatment with the device at zero, three, four and twelve weeks, respectively;

fig. 12A is a schematic diagram of an operation example of a conventional negative ion generator and main body circuit; the method comprises the steps of,

fig. 12B is a schematic diagram of an operation example of a main body circuit used by the apparatus for generating cold air plasma;

FIG. 13A is an image of an example of an intentionally made crack in a housing showing evidence of an electron path;

fig. 13B is a schematic diagram of an example of an insulating member;

fig. 13C and 13D are three-dimensional rendering diagrams of examples of insulating members; the method comprises the steps of,

fig. 13E and 13F are images of examples of insulating members within an apparatus that generates cold air plasma.

Detailed Description

An example of an apparatus for generating only negative ions will now be described.

In the present example, the apparatus includes a housing including a plurality of spaced apart openings and a plurality of needles, each needle positioned in a respective opening. In one example, the openings and needles are circumferentially spaced apart within a housing having a circular shape in top view, although it will be appreciated that other arrangements may be used.

The apparatus further includes a drive circuit that generates an electrical signal that is applied to the needle to generate a pulsed electromagnetic field (PEMF), wherein the electrical signal is alternated at a carrier frequency and modulated at a pulse frequency to generate negative ions.

In one example, the physical construction of the apparatus is substantially similar to that of the negative air ionizer described in US 5,973,905, and an example of such a prior arrangement will now be described.

Referring to the drawings and initially to fig. 1 and 2, there is shown a negative air ion generator 10 which is generally mushroom-shaped having a narrower cylindrical body portion 11 and an upper enlarged cylindrical body portion 12. The negative air ion generator 10 is provided with a circular array of needle emitters 13, the total of eight needle emitters 13 and four are disposed on the upper body portion 12 generally in opposite directions. Ground rings 14 positioned below the ring of emitters 13 at a separation distance D of about 17mm are shown in dashed lines, the ground rings 14 being placed at 15mm to 20mm intervals, as shown, 17mm being optimal for generating small ions. Each emitter is located in a recess 15, each recess having a slot 16 for the flow of ions between a needle point 17 and a ground ring 14.

It can be seen that the anion generator is relatively compact compared to prior art devices and includes high voltage circuitry on the plate 30, and control circuitry 31, separated within the cell using a 1mm thick polycarbonate insulating disc 32 disposed between the plates 30 and 31.

Referring now to fig. 3 and 4, there is shown a needle emitter assembly 13, the needle emitter assembly 13 having a replaceable needle tip 17, the needle tip 17 being releasably retained in a second connector 18 shown in cross-section. The second connector is also releasably retained in a first socket of a first connector 19 comprising a pin 20 adapted to be soldered in a circuit to provide a fixed connector having a socket configured internally in a similar manner to the socket shown in cross-section in figure 4. Both connectors 18 and 19 are configured to have the same general internal configuration with a plug 21 and a socket assembly 22, the socket assembly 22 having an inner sleeve 23, the inner sleeve 23 having resiliently biased legs 24, the resiliently biased legs 24 being adapted to frictionally engage the needle tip 17 as shown in fig. 3, in the case of connector 19, the plug 21 when the plug 21 is inserted into the socket of connector 19.

In this configuration, the replaceable needle 17 is retained within the second connector (fig. 4) 18 having a hub assembly 22, the hub assembly 22 including an inner sleeve 23, the inner sleeve 23 being retained within the second housing portion 100 of the second connector 18 such that the inner sleeve 23 and the housing together define a second hub that receives the replaceable needle 17. As shown in fig. 3, the socket assembly 22, and in particular the second housing portion 100 of the second connector 18, has a plug end 21, the plug end 21 being received within the first housing portion 102 of the first connector 19, the first housing portion 102 being the first socket of the entire needle assembly 13 and being insertable into the ionizer housing.

In the illustrated embodiment, all surfaces of the connector 19 and the connector 18 are gold plated to minimize any corrosion or defects on the shoulders, edges that may result from corrosion, which may provide a place for ions to be generated and thus shorten the overall life of the needle assembly. In addition to the gold plating described above, the needle itself may be formed of a corrosion resistant material, such as a ruthenium alloy. The coating and/or the needle may comprise different densities.

It will be appreciated that it is preferable for the ions to be generated at the very tip 25 of the needle tip 17, rather than at other locations on the needle assembly. The use of a corrosion resistant coating enhances the generation of ions at the needle tip and extends the life of the needle assembly.

In one example, the negative air ionizer uses a Cockcroft Walton voltage multiplier, shown generally at 31 in fig. 7, to generate a high voltage of between 5 and 13kV from the ferrite tuning transformer 104 in fig. 6 driven at 17 kHZ. This provides a more stable and medically efficient output than existing devices.

In this unit, the main power supply is switch mode regulated and converted to 12 volts DC via a custom AC mains adapter, which is then regulated to 10 volts DC for driving the main control circuitry. This includes a microprocessor 26, the microprocessor 26 being a crystal controlled by a crystal oscillator X1 shown generally as 105 in fig. 6. This in turn is modulated under the control of switches 6 to 8 on DIP (dual in-line package) switch 27. As shown in fig. 6, the pulse is fed to transistor circuit 28, transistor circuit 28 first to transistor Q1 and then to transistor Q3, transistor circuit 28 energizing the capacitively tuned pulse transformer 29 to operate in class C mode. The drive for this is limited by a set of resistors at 30 which can be selected by switches 1 to 5 at DIP switch 27 to give a range of ion outputs. The transformer 29 is used to generate an output voltage which is in turn multiplied by a five-stage voltage multiplier 31 shown in fig. 7 to generate the high voltage required for ionization.

An alternative arrangement 28' of the Darlington (Darlington) drive circuit 28 is shown in fig. 8. In this arrangement, the coil resistance of the resistor R4 is kept constant at 1 ohm, and the set of switches SW1 to SW5 changes the setting of the variable voltage regulator LM317 (106). By changing this setting by switching with different scaling factors, resistor groups R5, R7, R3, shown as 108, 109, 110, 112, 113, 114, 115, and 116, respectively; r2 and R13; r9, R12, R6 and R11 correspond to the different ratio coefficients described above. This strategy allows the inductance of the transformer 104 to be varied and by switching the settings of the two scaling factors in parallel, the ionizer can give 9 output voltages from 5 switches of DIP switch 27.

This modulation turns on and off the pulse train at a rate controlled by the switches 6 to 8 of DIP switch 27. It can thus be seen that the ion generating signal can be frequency modulated with a modulation frequency selected from a frequency range and can be frequency modulated with a modulation frequency that can be selected by changing the setting of DIP switch 27, in particular the setting of the 6-8 switch.

However, the existing arrangement includes many modifications to the device of US 5,973,905, leading to improved functionality. In a specific example, this allows the device to be used for treating biological subjects, in particular to provide a "whole body selective adaptogen response", so that the device can be used for treating a wide variety of medical diseases or other health conditions.

These benefits may be achieved by having the device generate a pulsed electromagnetic field to generate cold air plasma species (and in one example, quantum cold air plasma species) including, but not limited to, reactive nitrogen oxide species (RONS), reactive Oxygen Species (ROS), singlet oxygen, and their complex quantum and atomic air species of negative and/or neutral polarity and/or their counter-particles that move at speeds with fast spin and atomic heat, but are cold to the touch. In one specific example, the voltage power requirement becomes stronger without generating ozone to produce singlet oxygen, a preferred neutral air species of antioxidants, because it transfers its energy to molecules and macromolecules before returning to its ground state, exciting them and supporting them to produce macrophages. This combination is a specific example of a selective adaptogen process. The proper configuration of the amplitude, shape and spin of the PEMF in the circuit then creates a complex delivery pathway (portal) to rapidly and safely deliver all air species (substances) to the subject from a bio-beneficial perspective.

In one example, the air species is combined with energy from the PEMF through an electrical circuit to interact with the Central Nervous System (CNS) via the vagus nerve within the respiratory system as a sort of retrograde transport, thereby providing a direct pathway for CAP material across the blood-brain barrier (BBB) and allowing the material to induce effects within and use the subject's own hormones and immune responses, another example of the use of selective adaptogen functions of the subject's own system for biological needs from CNS specificity to the subject's own.

In a specific example, the device is used by placing the device in their proximity while the subject sleeps, for example by placing the device within 1m of the subject. As a result, the effectiveness of this arrangement is enhanced because the blood serotonin level naturally decreases during sleep, resulting in an increase in the protective blood melatonin level. This ensures that CAP apoptosis, caused by the damage of harmful cells and elements by substances, induces a natural immune response, thereby providing a corresponding specific protection mechanism needed for the subject and determined by the biology of the subject itself.

Numerous tests have shown that there are no adverse health events and no recall, and that a range of different positive biological health results can be repeatedly and consistently obtained, as will be discussed in more detail below.

To facilitate this process, and contrary to the teachings of US 5,973,905, the present apparatus uses an electrical signal with waveform mixing to create a so-called "transmission path", and in particular, the electrical signal includes one or more complex waveforms, such as, but not limited to, fourier modified waveforms, saw tooth waveforms, and in one preferred example, the electrical signal has a shark tooth waveform. Such waveforms result in complex pulsed electromagnetic fields, facilitating the transport of CAP from the tip of the needle, and causing the diffusion of CAP material into the body via air/mucus exchange of the respiratory system, and/or into the skin and whole body and/or around the whole body through percutaneous application using electroporation and/or plasma electroporation. Furthermore, the use of a combination of additional and multiple concurrent waves creates a "transmission path" and if there is interference, can help return the air species to the waveforms required by the subject.

In one example, the carrier frequency is in the range of 17kHz to 18kHz, 17.25kHz to 17.75kHz, or 17.4kHz to 17.6kHz, and in one example, preferably has a frequency of about 17.5kHz + -0.25%. It has been found that by more tightly constraining the carrier frequency in this way, better control over a particular medical treatment is provided, which can be tailored based on the pulse frequency and other variables used.

The pulse frequency is typically in the range of 0.1Hz to 40Hz, and by allowing pulses in the range of 0.1Hz to 4Hz, the range described in US 5,973,905 is significantly extended. In one example, the apparatus is configured to allow pulsing at different set frequencies including any one or more of: greater than or less than about 0.1Hz; about 0.5Hz; about 1Hz; about 2.5Hz; about 4Hz; about 7.83Hz; about 8Hz; about 10Hz; about 16Hz; about 25Hz; about 32Hz; about 40Hz. The pulse frequency signal may also have different signal amplitudes, resulting in different treatment intensities and/or intensity effects. To achieve this, user input is provided, such as one or more input buttons that allow selection of a desired pulse frequency and/or amplitude, thereby allowing different treatment options to be performed.

The frequencies are selected such that the treatment object and the device or the disease and the device interact as a "tuned system" of two oscillators having the same resonance frequency. Air species oscillations are the result of PEMF, circuit and mechanical design, thus causing the body of the subject to be activated by signals approaching the same resonance, which in turn enhances the effect of the treatment by maximizing the biological response induced by air species and circuit energy.

In the present example, the driving circuit includes: a rectifier configured to be attachable to a mains power supply; a switch mode power supply coupled to the rectifier; a pulse transformer coupled to the switched mode power supply; and a voltage multiplier connecting the pulse transformer to the pin.

The pulse transformer has 178:1 and which is configured to produce an output voltage between AC peaks of 3500-4500 volts, which is multiplied by a multi-stage voltage multiplier configured to produce an output voltage of up to 13000 volts, which is applied to the needle to produce an electrical signal having a voltage at the tip of the needle of greater than 12000 volts, and which is typically in the range of 12000 volts to 14000 volts, or 12500 volts to 13500 volts, and preferably about 12500 volts ± 2%.

The apparatus uses a different transformer configuration to increase the initial voltage and reduce the tolerance compared to the arrangement of the existing equipment in US 5,973,905, so that the resulting PEMF has a larger amplitude at a stronger current, more precisely controlled frequency. This allows improved transdermal penetration and allows more cold air plasma-forming air species to be generated at the needle while controlling the output to reduce and/or prevent the generation of harmful ozone, which in turn allows the device to be introduced into a placement theory model at this time as another method of treatment of the treatment subject because of the more variable distances affecting the intensity applied to the treatment subject.

In one example, the drive circuit includes a bridge resistor arrangement bridging the AC mains adapter transformer, the bridge resistor arrangement providing a ground reference via a neutral line of the AC mains power supply. The transformer used in the AC mains adapter is also a pulse transformer. In one specific example, the arrangement of the pulse transformer and rectifier and the switch mode power supply is provided in an ac mains adapter, and fig. 9 shows one such example.

In this example, the AC mains adapter includes international plug connectors in the form of live plug pins and neutral plug pins configured to be plugged into a main electrical outlet. The AC adapter delivers regulated DC power via a barrel plug that connects to a barrel socket in the housing that is recessed within the housing to reduce static charge build up. The DC supply is thus referenced to AC mains ground via the bridge resistor described above, providing a return path for electrons emitted from the voltage multiplier to generate ions. The return current path allows electrons stripped from the ions and/or molecules to return to the device via the treatment object, which may achieve enhanced therapeutic benefits, as will be described in more detail below. This can occur, for example, as a result of electrons being stripped from the ions upon, during, and/or after the generation of the RONS, and/or as a result of electrons being stripped from the ions leaving the molecule in the body. In one example, the current path is via a ground connection, for example in combination with a conductive ground pad on the bed or chair, although this is not necessarily required, and alternatively, an additional return path may be provided by using a physical wire connection between the treatment object and the device, for example using a conductive wristband or the like connected to an electrical ground of the device.

Pins 951.1, 951.2 are connected to the rectifier 953, while live pin 951.1 is connected via a fuse. The output from the rectifier is connected in series with the input of a switch mode power supply 954 and a pulse transformer 955, which causes a switching DC current to flow through the transformer. The output of the pulse transformer 955 is connected to the regulator 956 and to the connectors 957.1, 957.2 of a barrel plug that is connected to a barrel socket in the housing that is recessed into the housing to reduce static charge buildup. The output from the transformer is a regulated AC signal having a maximum supply current of about 120mA at 13KV and 40Hz, which is provided to internal components within the housing, including the voltage multiplier.

The bridge resistor arrangement comprises two or more resistors in series, which comprise a total resistance of about 20mΩ. This also serves as a safety mechanism in the event of a mains ground terminal failure, preventing unwanted current flow from the AC mains to the DC power supply for the product, thereby using two or more operator protection means. Furthermore, assuming that the mains system is referenced to ground with the neutral line, which in practice is taken as the common ground provided for the treatment object and the new circuit, the bridging arrangement provides a ground current path via the neutral line of the mains electrical supply. This circuit means that the small, extremely fast, short-lived and long-lived charged substances required reach the mucous membrane without generating harmful ozone and without the path colliding with air nuclei and water molecules in the ambient air slowing down their speed. PEMF currents promote and push air species transfer into a subject, push-pull energy transfer through the circuit results in the initiation of Ruach viability at the junction of these effects within the subject. Between the pushing of PEMFs and the pulling of the circuit magnetism, collisions occur where molecules stay within the treatment object and are excited by the Ruach vital force field caused by the abrupt stripping of electrons and quantum tunneling out of the body back into the vertical circuit. Such Ruach vital force fields generated between the pushing and pulling of circuit collisions generate photons inside the body for the generation of new molecular interactions and photon wave frequencies generated inside the body as energy stores protected by water molecules inside the body. In particular, electrons and neumots are attracted to ground via the treatment object due to circuit pulling forces, which cause them to travel through the treatment object while looking for ground at magnetic speeds. This series of events helps provide a whole body selective adaptive biological process to immediately and safely initiate and complete the use of the current evoked bio-intelligence of the subject, and for up to several hours. Thus, the spinning thermions carry excess electrons into the living body of the human body and then a fusion event occurs, which is caused by the abrupt stripping of electrons from the ions, thereby making it now the only molecule left in the body. This event results in a fusion event, which generates an optical discharge (photon). This Ruach viability is an energy and when it occurs, produces a cell voltage that is sufficient to produce hydrogen (H2) as a result of the induced water electrolysis. This energy is then protected by water molecules in the body for several hours, while the electrons return to the device ground, thereby generating secondary electrons.

As previously described, the device is configured to be able to generate an air species at the tip of the needle, typically by a type of corona CAP discharge plume, which occurs when a high voltage is applied to generate PEMFs that are strong enough to produce a chain reaction of electrons that collide with atoms strongly enough to ionize them, the chain reaction producing more free electrons to ionize more atoms, resulting in CAP RONS air species at the tip of the needle and within the mm order of magnitude of the discharge plume. To achieve this, the apparatus typically includes a plurality of gold plated needle assemblies in electrical contact with the voltage multiplier, each needle assembly being configured to receive a respective needle. The needle includes a shaft configured to be attachable to a needle assembly within the housing and a tip protruding into an opening in the housing. The needles are circumferentially spaced around the device, with each needle generating a plasma. The housing is made of a medical grade plastic resistant to gas venting to provide additional protection for allergic patients while adding robust quality and high voltage protection.

Currently, the length of the needle's shaft is about 60% of the needle length, which helps to improve the generation of higher electron output in order to generate quantum species inside the plasma plume at the tip of the needle. In particular, the needle has a thicker shaft and head than the needle of US 5,973,905 to carry a greater voltage over an additional 4.28mm span over the needle length itself. The taper here starts at 60% of the needle (4.28 mm), which increases the surface area of the electron energy up to the tip of the needle to assist in the generation of air species without increasing ozone production.

The needle is typically made of a corrosion resistant RoHS (hazardous substances limiting) metal mixture, treated to ensure smooth and sharp consistency, while the needle assembly uses a thicker and denser gold layer with finer depth and tolerances and higher quality gold allowing for a lower resistance connection which in turn allows for a higher needle tip voltage, thereby improving the generation of air species without generating more ozone.

In this regard, the original device is typically only configured to be capable of generating 50000 to 400000 anions per cubic centimeter at a distance of "one meter" from the device. This new and improved design now typically generates about one meter per cubic centimeter from the equipment

900000 anions, thereby significantly changing the device air species, from just "negative air ions" to the present "CAP air species and other quantum air species" having both negative and neutral polarity, for improved treatment of various kinds.

The ability to generate such high rates of electrons and other quantum air species inside the CAP for traveling through the circuit at magnetic (light) speeds is particularly beneficial for achieving human biology (e.g., pathogen destruction and immune protection). Excited state O of oxygen, for example ₂ Is a very strong oxidizing agent, but is not a group called singlet oxygen in its quantum state ¹ O ₂ Or O. It acts like a neutrino. All its electrons spin in pairs, so it is charge neutral and its decay rate is slow (54-84 ms) although it is kinetically unstable in ambient air. As observed by its electron paramagnetic resonance, it is paramagnetic because of its net orbital inversion (rather than electron spin) and electron angular momentum, and because it is attracted by a magnetic field at right angles to the electric field, exciting the formation of an internal magnetic field, its path in the transport path circuit is above and below the electric field.

For example, O ₂ Water, calcium, blood and fat are weakly diamagnetic and are therefore sharply repelled by the magnetic field. The human body is mainly water and diamagnetic, when a person is grounded to the earth through the device, in which case the applied PEMF and strong electromagnetic current induce a strong diamagnetism and cause the formation of a magnetic field opposite to the external field, so that after the superconductor (in this case the earth ground potential of the person) as a strong diamagnetic source fed by the circuit power, the particle-biennial electrons are returned by the circuit transmission path. Thus, when a magnetic field is applied to the body, it generates an induced magnetic field in the opposite direction, thereby causing a repulsive force entirely from its interior, and thus a partial pulling force suddenly Electrons are stripped from the molecules in the body and quantum tunneled back to the transport path circuitry for transport to the ground ring destination inside the device.

¹ O ₂ Is the main substrate of microbial photooxidation stress (photooxidative stress) and reacts with a variety of macromolecules (including proteins, lipids, DNA and RNA) to form organic peroxides and sulfoxides. It is essential in mitochondrial electron transport, fatty acid oxidation and vitamin metabolism. Microorganisms (such as carotenoids) facing high light intensities have a protective mechanism which is associated with ¹ O ₂ In response to prevent further impairment of cellular function, to allow for equilibration by systemic selective adaptogen activity. Furthermore, since in this case the electron spin is zero, this results in its destructive behaviour towards respiratory pathogens (such as viruses), while on the other hand its impact with the aqueous solution of the upper respiratory system generates hydrogen peroxide H of the human body itself ₂ O ₂ To selectively accomplish the inhibition and sterilization of the upper respiratory tract, while decomposing and regulating ¹ O ₂ And is protected from further damage. Thus, the body itself adjusts to its own pace.

To understand the importance of size and speed in the atomic and molecular world, singlet oxygen ¹ O ₂ Is approximately 0.00014 μm (0.140 nm), the oxygen anion O2-is approximately 0.00012 μm (0.1 nm), and the size of the free flowing energetic electrons is 5.64X10 ^-17 μm or 0.00000000000000564, significantly smaller. When generated at the tip of the needle inside the cold air plasma plume, the air species are cold to the touch, but atomically hot, as they are generated at high energy, high force, high flow rate, and get fast spin and thus atomic heat.

PEMFs and electromagnetic currents in the transport pathway protect singlet oxygen and other quantum air species as they travel into the human organism where they are magnetically attracted by the oppositely charged exotic viral capsids and can be destroyed by a large number of air species with vibratory heat, resonance, frequency mirroring and energy effects. For example, this mechano-physical disruption resulted in successful treatment of the SARS-CoV-2 enclosed icosahedral capsid symmetry, which was much larger in size, about 0.12 μm, and therefore the large air species generated by the device was significantly smaller, about 0.000000000000000564 μm, indicating that it could easily penetrate the lipid barrier and spike protein to enclose all 20 triangles of each capsid by their oscillating heat and combined Ruach vitality energy collisions, and the photons of the generated light could destroy and rupture the capsid, effectively bursting it open and inactivating its contents by mechanical physical forces. Furthermore, since CAP is selective, any damage to cells is corrected by the subject's own initiated immune, redox and other natural biological responses. Finally, cell membranes, intercellular and intracellular fluids of the subject can retain memory for all of these responses. Such stored memories have demonstrated the ability of future pathogens to protect a subject from future pathogen infection, either as a whole or by reducing the severity of future pathogens. Thus, up to 2800 tens of thousands of ions/cc can be produced at a flow rate of 50.1 trillion ions/sec at a distance of 300mm, and 900000 ions/cc can be produced at a distance of one meter without any higher levels of ozone, which allows improved treatment in more subjects within the bioactive range as a whole body selective adaptogen.

The air species fly out of the CAP plume from the tip of the needle, is pushed into the treatment object by the PEMF-driven PEMF delivery path, and is then pulled into the treatment object by the circuit force after collision, in the process this creates a Ruach life force field, while electrons are separated from the molecules to magnetically re-enter the delivery path circuit seeking the lowest potential they can find, which is anything connected to the electrical mains system, including the actual earth. When air species collide with a grounded conductive surface (in this case, the conductive grounded person is the path), they lose excess electrons into the current to flow through the transport path to the ground path. The circuit is completed by a special isolation bridge retrofit in the AC mains adapter, and then the electrons are returned to the device ground ring via the gap under the needle structure where they are lifted to a high potential and again ejected into the air to form more CAP air species. Since this new circuit is self-implementing, air species flow from the device through the person and back into the device at magnetic velocity to complete the circuit, creating a gentle ionic breeze or wind without a motor. Thus, the air species moves at the magnetic speed (near the speed of light) we know today, as the polarity causes the electromagnetic to pull it back to the lowest potential. This is a complex process that brings about a large number of active mechanisms that are biologically inexhaustible, but can be generalized to help the body reach homeostasis in a "whole body selective adaptogen" fashion.

It is known in theory that, due to this new circuit cycle, elementary particles like mesons also participate in it with different mechanisms and assist the security forces and charged energy particles in the human body. Muons are generated when energetic protons collide with nuclei of molecules and produce pi-mesons that interact strongly, which holds the nuclei together (e.g., ruach vitality). The muons carry energy and momentum that react with the PEMF and the pull field of circuit ground, producing high energy photons. Such force fields cause collisions of push-pull effects through the body and strip electrons (light photons) from the molecules and/or hydrogen atoms, allowing protons to pass through the body, which continue to accelerate until they collide in the circuit with anti-protons (an enhancer of quarks). Muons, pi-muons and their associated elementary particles travel from the sun through our body at a rate of 10000 muons per minute per day. Muons do not decay, they can persist forever, but they are characterized by strong fields that become electrons, mesons and anti-mesons, constituting Ruach vitality, and when they interact with the water of the human body, electrons or positrons are generated, giving off a weak-light ring pattern. Negatively charged particles also include anti-protons, pi-mesons, and other particles. In 2015, the CERN announced that the neutravertine can accelerate to faster than the speed of light. This cannot be observed, but their behaviour and the behaviour of electrons can be demonstrated by bending their flow in a natural gravitational field as evidenced by the traces they leave when they move in the device.

In one example, the apparatus includes up to eight needles circumferentially spaced around the circular housing. However, in use, not all of the needles need be used, and the device may include one or more caps configured to be positioned in the opening to selectively deactivate one or more of the needles. In this regard, the particular needle configuration used will vary depending on the intended application.

For example, when used to treat multiple subjects, four subjects are treated at a time around the device, or all eight needles may be used in order to reduce airborne and surface pathogen particles, such as in a drug storage room. However, when treating a single subject, a four-needle configuration is typically used, with four adjacent needles on the side of the housing nearest the subject to maximize the selection of the type of air generated.

The device is generally configured to generate a pulsed electromagnetic field (PEMF) that propels air species from within the cold air plasma plume through a delivery path into the air outside the tip of the needle, proximate to the housing, and/or transporting the air species out of the housing. Since the human body is now in the center of the circuit due to common ground and engineering factors, the wave-particle bisexuality and the air species and ground arrangement inside the PEMF act together, accelerating the air species to the target at high speed, which helps to increase biological benefit and deep human penetration, thus improving biological outcome. In addition, PEMFs are safe to react because they are exposed to moisture on the skin, and have percutaneous absorption pathways for substances to enter the skin by utilizing plasma perforation and electroporation techniques.

The increased operating voltage facilitates this but nevertheless the device produces less ozone than previous devices, making it safe for use in a wide range of systemic therapeutic applications, across all ages and types of co-existing diseases, such as treatment of respiratory diseases including asthma, chronic obstructive pulmonary disease, emphysema, allergies, autoimmune diseases, sleep apnea and other sleep problems, pathogen infections including bacterial, viral and fungal infections, but not limited to SAR-CoV-2, ross river fever, lupus and any mutation, treatment of cancers including basal cell carcinoma, breast cancer, lung cancer or glioblastoma, kidney cancer or liver cancer, or treatment of diabetes, wounds, burns or eczema, dermatitis and psoriasis, blood pressure, hormonal diseases, depression, fatigue and the like, and safe treatment with any drug. The device is a physical solution rather than a chemical solution for systemic conditions and thus can be used with all existing recommended drugs, drugs and/or vaccines without interaction or negative consequences.

In particular, the device is configured to be able to provide a whole body selective adaptive response to achieve homeostasis and therapeutic and biological benefits in a wide variety of disease types controlled by the body system; causing apoptosis; interaction with the central nervous system through the blood-brain barrier to induce immune, hormonal and all other systemic reactions, for example by interaction with one or more of serotonin, melatonin, lycopene, and glutathione; at the same time, creates a correct environment for more complex immune, apoptosis and protective responses of cells and systems in the body. For example, the fluid pathway between macrophages and cells and the system and bioelectric currents throughout the human body. All these and other reactions require the initiation of the Ruach vital force field to generate photons, energize atoms and molecules, and exceed the treatment time until the next 24 hours and create the best environment for the subject's own biochemical reactions.

One example is the destruction of pathogens by high energy radicals using OH hydroxyl radicals that are reactive but safer than ozone and have a short lifetime, which propagate within 1 nanosecond at 1200eV, and can also propagate at H ₂ O ₂ Is formed during the electrochemical oxidation process of (a). OH, which consists of one hydrogen atom and one oxygen atom, can only be negatively or neutral charged. When a positron collides with an electron due to attraction, it is annihilated by quantum electromagnetic radiation, and a photon is also generated. The photons beingThe basic unit of light, which is about 2.998 ×10 ⁸ The light velocity propagation of m/s is generated by the combination of collision circuits that push the air species and then suddenly pull the electrons, resulting in Ruach viability collisions within and/or on the subject.

In one particular example, the device creates a new quantum and CAP air-like cocktail that, when combined with PEMF delivery pathways and Ruach vital force fields, provides retrograde transport along the nerve, which enables them to interact from the vagus nerve of the respiratory system across the blood brain barrier and affect the brain, autonomous system and the entire central nervous system through adaptive and cell-mediated immune responses, particularly but not limited to, the effects of ceratin, melatonin, lycopene and glutathione on T cells, as well as humoral immune responses controlled by activated B cells and antibodies. These produce a systemic selective adaptogen response in humans.

The ion delivery system of such devices, particularly the connection to the treatment object, and the resulting internal mechanisms, result in a very different mode of operation than conventional ionizer devices.

An example is shown in fig. 12a and 12b, comparing a conventional ionizer with the current device circuitry. In conventional ionizers, negatively charged anodes in the ionizer repel negative ions. Insulated and/or ungrounded conductive objects, including treatment subjects, accumulate negative charge in the form of static electricity and begin to repel more negative ions. Electrons and ions find the nearest ground path in the environment, such as metal or ground circuits in surrounding buildings, and are therefore removed. In contrast, in the current devices, there is one return ground path, which means that the treatment object is grounded and acts as a cathode, attracting negative ions. Activated molecules in the body of the subject are ionized, the molecules remain in the body, and electrons are stripped off, suddenly returning to the device via a ground circuit called the delivery path. This represents the inner loop (or first transfer path) in fig. 12 b. The returning electrons are accelerated to form a secondary electron loop, as shown by the outer ring (or second transport path) in fig. 12 b. In this case, the second transfer path is guided Generating electrolysis in a cathodically (subject), wherein H ₂ O can be split into H ₂ And O ₂ A gas, as will be described in more detail below. Thus, in the current device, O ₂ (and other air species) are ionized at the anode and accelerated toward the treatment object. At the same time, the secondary electrons are more energetic and then hydrogen H is generated in the treatment object ₂ Resulting in multiple modes of metabolism that are primarily metabolized to the entire body.

Thus, in current devices, the needles generate electrons and charged ions in the high potential corona plasma plume, but they do not go anywhere without a return path, they simply scatter into the environment. The charged ions leave the needle, travel in air with the doublet of the carrier frequency and other quantum waves, and are driven by PEMF and other forces toward the lowest potential they can find. The lowest potential is anything connected to the power supply system, including the actual ground, or in this case a custom designed ground ring of the device. When ions collide with a grounded conductive surface (treatment object), they lose excess electrons and cause current to flow through the ground path. The circuit is completed by an engineering forming a first transport path which attracts electrons from the needle through a common grounded person back to the device ground ring via a new isolation bridge which attracts electrons into the ground ring like a very powerful magnet. The now further excited electrons find their way out of the ground ring, back onto the needle assembly, are then lifted to a high potential, and are again ejected into the air by the plasma, creating "secondary electrons", or a second transport path. The electrons return to the beginning of the circuit again and now create a second life of the transport path, which becomes a repetitive cyclic process, but at a very high magnetic velocity. The secondary electrons carry a higher momentum on entering the second transport path, as it has already passed the first transport path process, where it is considered to have acquired a large energy transfer.

To obtain the desired therapeutic health benefits, the ions must be in contact with the human body at extremely high velocities to maintain their purpose, i.e., extremely small size (smaller than atoms), velocity, and flexibility, and thus this mechanism allows for the passage through the blood-brain barrier. It is known in physics that when a surface, in this case a human body, is hit by charged particles of high kinetic energy, these electrons are emitted and considered secondary electrons, and furthermore, the solid matter may release more electrons, as described in Dekker AJ, secondary Electron Emission (secondary electron emission), "Solid State Physics", springer Link 1981, pages 418-45. In this case, quantum tunneling can penetrate the object in two ways, so this theory can explain some of the secondary electron behavior. If a person is properly grounded, they will receive more ion current to pass through their body. To achieve this they can sleep on an electric blanket, ground pad, light feet in the office, or wear a wristband connecting the body and ground so that PEMFs push ions towards their body. This force can be considered as a gentle and quiet "ionic wind" (breeze) exiting the needle.

Conversely, if the subject is not grounded, a smaller number of ions will flow to them, and they will experience much less "ion wind" (if any). In this case, ions will tend to accumulate on the body as static charges, with the result that if humans subsequently touch the surface, they will experience a harmless strike when they touch the conductive path to ground; similar to touching a vehicle door in dry winter.

The charge is designed to return to the device through the treatment object, as long as the treatment object and the device are properly connected to each other together, which need not be through a cable, but rather through a ground path as shown. Secondary electrons move from the human body back to the CCAP device through the transfer path at magnetic velocity without using more ac power, and thus, adverse events of excessive ozone, which may be harmful to human health, are not likely to occur. Experience and observation of electron trajectories indicate that molecules do not travel farther than the subject. Because an ion is a molecule with excess electrons, once the molecule has reacted in some way with the chemical substance of the body, the ion is no longer present in this way, because the electrons then escape, but they escape in the form of a conductive charge, whereas the molecule is absorbed by the body.

Electron escape occurs immediately and is stripped from the molecule under a sufficiently abrupt force to find its ground through the transport path and back onto its ground ring, which is a tailored place within the device. This completes one circuit, but it is a continuous loop. This occurs because the conductive charge of electrons leaves a trace that can be visually observed by engineers, while the human body obtains a number of therapeutic positive benefits from its energy retaining molecules. When an electron suddenly detaches from the molecule, some sort of bio-fusion occurs at the ion, which explains the generation of photons and the wavelets' two-image. In the field of quantum mechanics, it has been found that the origin of certain photon purities can influence its particles and waves, and that under appropriate conditions, particles can become waves, which can become particles, for example, as described in the following documents: yoon TH, cho, M.quantitive complementarity of wave-part quality.science Advances.2021;7. this expands the concept of wave grain bispin theory originally proposed in the following literature: wotes WK, zurek WH. Completions in the double-slip experiment: quantum nonseparability and a quantitative statement of Bohr' physical Review D.1979;19 (2): 473-84. This process accounts for quantum tunneling effects that occur when electrons travel from ions through the body and back to the ground transport path.

As previously mentioned, in one example, this creates the ability to generate hydrogen in the body by water electrolysis.

In this regard, hydrogen plays a key role in metabolism and dynamic balance of the human body. Hydrogen, which is known to be beneficial to humans in tablet or water form, has recently been considered for use in molecular form in the treatment of covd-19. It is the main stabilizer of human body moisture and is also a unique element for blocking DNA strand distortion. The body stores a large amount of H ₂ Supply for future use by the body, and H ₂ Protecting the body from free radicals. It is a powerful antioxidant, accounting for about 10% of the human mass, see literature: alwanzer D, liu FF, wu XY, leBaron TW.Combating Oxidative Stress and Inflammation in COVID-19 by Molecular Hydrogen Therapy：Mechanisms and Perspectives.Oxid Med Cell Longev.2021；2021：5513868。

The results of subjects strongly suggest that there is a major metabolic mechanism in play, which is required to explain their long-term positive outcome over a wide range of human health. The theory and mechanism behind new circuits and water electrolysis (the human body is mainly composed of water), quantum tunneling, maxwell's equations and a number of multidisciplinary sciences and the consequences for human health are an encouraging explanation that such medical devices produce hydrogen by splitting some water molecules within the human organism (H ₂ ) A kind of electronic device.

The water is very stable and does not naturally decompose into oxygen and hydrogen. Only when one energy is used to decompose water, it is possible to become its constituent elements. Currently, scientists have not yet known methods to test this experimentally, but the results of theory and subjects indicate that this technique has a fairly high probability of hydrogen (H ₂ ) The creation of (c) creates a correct environment and thus hydrogen is produced inside the human body.

Tests on the electronic trail have shown that this is likely to occur at the interface of the central circuit between the two transport pathways where ions and molecules are in the body and react with chemicals in the body. Thus, in the current devices, charged molecules remain in the body, as evidenced by numerous positive therapeutic results, engineers have demonstrated evidence that electrons are being moved out of the body, particularly back to the device through the return current path. This can be demonstrated by the aging of the anode within the cold air plasma generating device in a specific area associated with the electron return path. It is also possible to trace its spill during travel by deliberately creating a hairline slit, thus seeing the trace as a secondary electron tunneling back to the needle assembly.

Secondary electrons include higher charge and velocity. Although it cannot be seen or measured, the aging path of the internal components of the instrument can be tracked by it. Events from secondary electrons are combined with such increased density circuitryTo produce hydrogen (H) by water electrolysis in a human organism ₂ ) Creating a suitable environment. In one example, the internal environment of the device is configured to assist electrons in reaching the ground ring and then returning to the needle assembly as secondary electrons while protecting the balance of the high voltage assembly from its subsequent increased aging-causing capability.

Since such modern methods are currently incapable of handling substances of electronic and other atomic size and velocity, in order to avoid minimal hair-like bubbles around the component at the time of application, conformal coatings (conformal coatings) cannot be used and the internal component has been shown to be damaged by application of the conformal coating. With current devices, a cold air plasma is generated at the tip of the needle, and then electrons are stripped from the air molecules to produce hydrogen (H) with improvements in higher ion density, flow rate and magnetic pull and fusion ₂ ) And attracts electrons from the body to ground, which requires a new solution.

To demonstrate this, we made various purposely damaged cracks on the outside of the various devices until a vertical hairline crack of uniform width was seen directly outside and above the ground ring and between the two needle assemblies, as shown in fig. 13A. Aging of the housing around the external crack reveals a naturally formed shadow, showing the behavior of the electron "inside" the device, as its spill "leaks" through the uniformly distributed crack. In the lower half of the crack, immediately adjacent to the internal ground ring, a concentrated darker shadow can be seen, indicating that the electrons are returning from the body to the internal ground ring of the device at high concentration and high velocity. In the upper half of the crack, a soft shadow shows that electron diffusion is offset to the upper left and upper right quadrants. These gentle shadows demonstrate the path of electrons after they have escaped the ground ring and been attracted to each needle assembly that is located above and away from the ground ring and further inward from the housing away from the housing. One set of electrons fans the needle assembly to the left and the other set of electrons fans the needle assembly to the right. This sweeping motion to each side is evidenced by electron flood shadows through the slits, where the electrons still move in the direction of their atoms' intended travel; when they reach each needle assembly, they are again charged to a high potential, becoming faster secondary electrons. The smoke appearance of the shell is caused by the electrons overflowing through cracks propagating from the inside to the outside, where it leaves us with a trace of its internal behaviour. The upper shadows are lighter in color, as they need to be moved further into the device to the needle assembly to escape the ground ring that is in contact with the housing, so a small portion of the spill can be expected to seep out of the crevice. The exuded electrons leave a trace of their presence, their density and the direction in which they progress. It has thus been demonstrated that the ageing of the components and the housing can be used to track the behaviour of the internal electronic substances and to monitor their consistency.

Accordingly, an insulator is provided within the housing to isolate the high voltage components, thereby reducing the effects of these stronger electrons on the housing and helping to direct the electrons to travel to the needle assembly by eliminating an alternate path. This in turn enhances the generation of secondary electrons. The insulating member typically has a curled shape so that it can enclose the high voltage electronics while providing a current flow path to the needle.

In one example, during testing, an insulator is provided in the housing in the form of a non-flammable, approximately 23.5 cm long trimmed, 25 mm high CD2516 cable electrical conduit tube that is manually tried to test, wrapped around the HV board member for protection, and retested. It was found to reduce aging and not interfere with the output measurements, but requires a lot of labor to implement into each device.

Thus, the insulating member is manufactured using the same outer grade of plastic for the device housing. As shown in fig. 13B to 13F, the insulating member has a curled shape so that the insulator surrounds the high voltage component, thereby reducing the flow of electrons through the housing. However, this still provides a current flow path to the needle so that electrons are removed from the charged molecules inside the human body after the ground ring is found, and then become the required secondary electrons at the tip of the needle to produce the higher required charge rate and higher required charge rate for water electrolysis to occur in the organism Speed and use of body's own water to produce hydrogen (H) ₂ ) To achieve the therapeutic effect, H ₂ Is a main metabolizing agent for balancing all systems of human body.

Maxwell's theory states that the atomic magnetic system acts at right angles to the molecular electrical system and that each of them changes over time at a rate proportional to the rotation of the other. Here, however, the field changes so that it points in the second direction, as the transport pathway pulls electrons from the ions in the body back to the device. Thus, its rotation is now perpendicular to both directions, so its rate of change over time will be the same as its own direction. During the separation of electrons, cold fusion occurs in the human body, which accounts for the generation of life photons in the human body known as Ruach's vitality, which is also the basis for the repeatable and consistent results seen in many target and non-target health conditions. This brings a reasonable argument that this same Ruach vitality and the resulting muons and pi-muons also create forces that combine our "planckian atoms and nuclei".

In view of the fact that the human body is mainly water, water electrolysis is possible under appropriate circumstances. These reactions require that the biological cell potential reach +1.23V or higher to be electrolyzed, as described in, for example: carmo M, fritz DL, mergel J, stolten D.A comprehensive review on PEM water electronics International Journal of Hydrogen energy.2013;38 (12): 4901-34; shiva Kumar S, himabindi v.hydro gen production by PEM water electrolysis-a review.materials Science for Energy technologies.2019;2 (3): 442-54, or acr C, cancer I.hydro production, computer Energy systems.3: elsevier Inc;2018.p.1-40. Although this is thermodynamically favourable in water electrolysis, its speed is still insufficient to break H ₂ O molecules unless it is ignited by some sort of "discharge". Stripping electrons from ions can cause a cold fusion discharge at the biological level, reversing their direction, leaving a rotating atomic thermomolecule, and quantum tunneling back out of the body along the direction from which it came. If the cell potential is reached, then new energy or Ru is generated at the moleculeach vitality and the photons formed thereby will be spontaneous reactions, since the body is very suitable for the occurrence of water electrolysis. Firstly because the systemic biology of the human body is composed of large amounts of water, buffer system managed salts and buffer system managed pH levels, and secondly because the extra pulling force from the transport action of the device pulls electrons out of the body. Therefore, the body becomes a closed circuit of the body itself, and the repeated flow of current is promoted, so that the body becomes an ideal environment for water electrolysis and cold fusion discharge initiation at the biological level. Furthermore, since the body's saline is attracted by current, engineering theory suggests that the body itself will become a closed loop, interestingly when it is a closed loop in a larger repeatable closed loop, at speeds approaching the speed of light (magnetic loop speed), from pass to pass until shut down.

From long-term (> 1 year) positive experimental results, yet another mechanism also accounts for metabolic sustained energy, which suggests that the likelihood of such cold fusion occurring is highly reliable. Such as the literature "Chen C, zanetete DH, czapewski DA, shaw S, lopez d.direct observation of coherent energy transfer in nonlinear micromechanical oscillator.nat Commun.2017;8:15523", the nonlinear coupling between dipole oscillators can deliver energy into a single coherent oscillator. As in the literature, "Kylechbekov S, song HS, kwon KB, ra O, yoon ES, chung M, et al Reconstruction of plasma density profiles by measuring spectra of radiation emitted from oscillating plasma dipoles.plasma Sources Science and technology 2020;29 (2) "or" Tysetski Y, vladimirov SV. Quantum-tunneling-enhanced charging of nanoparticles in plasma. Phys Rev E Stat Nonlin Soft Matter Phys.2011;83 (4 pt 2): 046406 "occurs inside the body, then fluid, interstitial fluid, water channels and body fluid currents inside the body can also resonate, which has now been demonstrated to activate cells.

The body is then able to store this energy for later use and activate it at biological temperatures, then enable the body to control its own chemical reactions as needed and time, as described in the following: trixler F. Quantum tunnelling to the origin and evolution of life. Current organic chemistry.2013;17 (16): 1758-70,Montagnier L,Aissa J,Giudice ED,Lavallee C,Tedeschi A,Vitiello G.DNA waves and water.Journal of Physics: conference series.2011; 306. Or Montagnier L, del Giudice E, aissa J, lavallee C.

Energy can potentially be surrounded or stored by water molecules in a manner similar to a DNA fragment diluted in pure water at a weak EMF of 7Hz, then its memorized resonance recorded on USB and reconstructed itself in another vial of water at another geographic location, such as document "montagner L, del Giudice E, aissa J, lavalee C, motschwiler S, capolipo a, et al, transmission of DNA information through water and electromagnetic waves. Electric bio Biol med 2015;34 (2): 106-12'. It is apparent that this is the level of the electromagnetic spectrum specific to the instrument resonance and its wave-particle bisexual PEMF and vibration; so that in the human result, which is shown outside the device, communication and memory occurs at this very low end of the human organism resonance spectrum (in this case < 10 Hz), and this requires PEMF and water. In addition, electron tunneling was found to have a short lateral time and allow H in water ₂ The O dissociation mechanism occurs.

The radioactive decomposition of water, in particular involving the radioactive decomposition of ionised species, shows improved hydrogen deuterium kinetic isotope effect and H at room temperature ₂ Splitting of the O molecules due to this quantum tunneling phenomenon is described in the literature "Nikitenko SI, di Pasquale T, chaveT, pflieger r.hypothesis about electron quantum tunneling during sonochemical splitting of water molecules. Ultrason sonochem.2020;60:104789", as described in the following. In the field of quantum electrodynamics, it is believed that in some circumstances similar to such devices, the low-energy coherent state of the electron cloud of water molecules (thermo-spin molecules present in the living being) oscillates between its excited and ground state configuration, thus resulting in one electron per molecule being free (binding energy 0.4 eV), since the coherent oscillation of the molecules is compatible with PEMF,see, for example, the document "Giudice EDea.coherent structures in liquid water close to hydrophilic surfaces. Journal of Physics: conference series.2013;442 (012028) ".

The mechanism in question is further supported chemically, as described in the following documents: scott k.chapter 1.Introduction to Electrolysis,Electrolysers and Hydrogen Production.Electrochemical Methods for Hydrogen Production.Energy and Environment Series2019.p.1-27, where at the polarized end of the transmission path shown in fig. 12B, in the circuit the device acts as anode and the person acts as cathode. The reduction takes place at the cathode (human), which splits the water molecules and generates hydrogen (H ₂ ) Gas, but oxidation occurs at the anode, i.e., the device. Electrons accelerated to the anode are received by the cap electron acceptor, and the charged electrons leave their trajectories, which can be observed by observing the aging of the anode destination created for it. This demonstrates the physical evidence of the electron return path, thus providing an understanding that the transport path configuration greatly promotes the electrical discharge required for cold fusion, which initiates splitting of water and hydrogen production in the organism (H ₂ ) The desired cell potential, while electrons are quantum tunneling back to their ground.

Water electrolysis shows that H++ e-becomes H at the cathode, but it is unstable so it combines with one another. So H+H then becomes H ₂ The amount of hydrogen formed in the body water will be twice the amount of oxygen formed on the device.

Many clinical studies are performed using the above-described device with new utility, and examples of these results and some variations will now be described. Furthermore, by month 8 of 2021, the apparatus was currently used by 72 subjects, each study being personalized, and subjects recorded their observations from 30 days to 12 months, involving a trial of a decentralized mixed clinical case study of 54 diseases. 100% of subjects with more than three complications show the systemic effects of the disease in our modern society.

Asthma case study (2,288,993)

One 60 year old female patient was diagnosed with asthma in 2010. The reported patient conditions were asthma and scoliosis, with a 25% drop in (L) lung capacity.

Patients agree to record baseline asthma conditions within 2 weeks prior to use of the device and determine the primary trigger as environmental: dust, exhaust gas, abrupt temperature changes, wind, and is sensitive to minor environmental changes. Patients were administered Shu Lidie (Seretide) 250mg, as needed, with Chuanlenin (Ventolin) 2 times a day. When these are not yet sufficient, the patient uses the nebulizer every 4 hours until the symptoms subside.

The patient was treated by using the apparatus at night while sleeping, placed at 1.5 meters from the center of the patient's pillow. The age and normal size of the patient generally means that we use an arrangement of the type of immunity. However, the patient indicated "oversensitivity" to changes in air conditions, so very weak settings were carefully tried, with settings of 4, 6, 7, 8.

After treatment, the patient reported that her common cough mostly disappeared in the daytime. She had stopped taking the steroid Shu Lidie and had only taken Mo Tuolin infrequently.

Asthma case study (2,289,000)

In another study, a 40 year old male was treated with mild asthma for 30 years. The patient weighs 89 kg. Non-smokers. Exercise is performed regularly. The temperature and humidity were respectively 22 and 50% on average.

The patient had mild asthma for 30 years. The inhaler was pressurized (2 times per day) with Salbutamol (Salbutamol) mitigant and clendi module 200 as needed. Allergens that exacerbate a patient's condition include cats, carpeting, cold air.

Results: comparing the 14 day baseline without the device; within a short 8 days of use of the device, the patient's O2 level increased by an average of 0.4 percent in the evening and morning measurements (using pulse oximetry). With this device, the peak expiratory flow was increased by 17.5% on average in the evening and 11.4% on average in the morning (peak flow meter used). Shortness of breath improves by 48% in the evening and 20% in the morning (self-rating).

Fatigue levels decreased 23% in the morning (self-rating), which is the expected outcome of the short-term analysis. This tells us that the patient sometimes responds and sleeps deeper in the evening, producing more of the effects of perceived fatigue in the morning.

Basal cell carcinoma research (2,288,991)

A patient with basal cell carcinoma in the posterior part of the right ear and on the cartilage was treated with the device.

The patient had previously selected not to receive any medical treatment, so after about 6 years, the cancer became a large ulcer-type wound that penetrated behind the ear, and the front was inflamed and swollen. The wound is open and painful, bleeding every few hours. The patient was previously informed that there was no treatment other than surgical removal of the entire external auditory canal, and he refused the surgery.

The device was placed on a bedside table at the bedside, at a high setting of 2 hours per day, within 30cm of the patient's ear during the day (3-4 Hz high intensity therapy), and at night (respiratory system therapy, 4Hz mild intensity), 1m from the patient's head when the patient was sleeping in a smaller setting. During this process, the wound is strongly exposed to the substance during the day, and systemic treatment of the body is exposed during the night when he sleeps.

Within 10 days, the wound size was reduced and no more fluid was allowed to penetrate. No pain is felt any more. The wound stopped bleeding within 20 days. The wound healed almost completely after 30 days. Patients reported that there were few wounds behind their ears for the first 5 years. Fig. 10A and 10B and 10C and 10D show comparative images before and after treatment, respectively.

Because of the good improvement of wounds, the current treatment focus is on treating the cartilage area by changing the way the patient is treated for 2 hours with high intensity. The device is now placed "facing" the side of the ear and face directly, rather than placing it "behind" the ear at 30 cm. The patient places the device one hour behind the ear, then places it directly against the ear on the face side for one hour, and wets the ear surface with water or a humectant. With caution, the patient wears the full set of eye protection devices.

During the course of treatment, at 9 weeks, the patient was required to use a conductive grounding pad (metal mesh) under the head while performing a high intensity treatment for 2 hours as described previously. The reason for this is to promote a more focused treatment by improving the conductive ground. The ear need not be resected.

Blood phagocyte study (UZZA 00015)

A study was conducted to investigate the ability of the device to enhance the immune system by aiding its ability to assist phagocytes in the blood to become excited and respond more effectively.

In vitro tests were performed using live blood from chronic fatigue patients. A live blood sample control was spread on a microscope slide and immediately observed in real time to show a picture of phagocytes that were inert in the blood and did not move, rather than merely float between cells.

The same blood sample was then placed in front of the device for a period of < 30 seconds and again observed under magnification, confirming that the phagocytes were now excited, illuminated brighter, flashing like a diamond, because we see that one phagocyte began to open and eat debris in the blood environment, acting in a more energetic manner, as we expected.

This is an effective sample experiment, simply indicating that phagocytes are more responsive in this particular initial experiment.

Glioblastoma brain cancer (2,289,005)

A58 year old male, 105kg, was diagnosed with glioblastoma. Some tumors were operated on, while the rest could not be operated on. The patient was sent home to palliative treatment and survived for less than 8 weeks. The patient tried the above device and hoped to help his breathing and snoring at night. The setting for the patient is a strong output but a low frequency of 2 Hz.

The patient reports sleep improvement and energy increases. After 5 weeks of treatment, his scan showed glioblastoma had stopped growing. By week 7, his doctor tells him that the tumor is shrinking. At week 12, his doctor thinks he is alleviating and he has returned to his favorite sport and normal life. The patient did not make other changes in his life nor took any medication.

Brain and lung metastasis (2,288,996)

A 25 year old male patient with end-stage metastatic brain and lung cancer was treated with the device. This patient had undergone multiple surgeries and the cancer had metastasized to the lungs, meaning that he left only half of the lungs after the surgery. His oxygen level was 88, which the surgeon could not raise, he was sent home to receive palliative treatment, as he was expected to have only 7 days of survival. The surgeon asks to investigate whether the device will increase his blood oxygen level during this time.

During treatment by the device, the patient's blood oxygen level is initially tested using an oximeter. When the device is first installed, the patient's O2 reading wanes between 86-88, and the patient is pale and weak, but mental well. The device (by the patient) is placed at about 20-30cm from the patient's breathing space, while he is sitting comfortably on the breath, still unchanged. After 36 hours of treatment, the patient's blood oxygen level eventually increased to 95. Thereafter, the blood oxygen level was maintained at this level all the time, and after 14 months, he was still with us and in remission.

Breast cancer (2,288,998)

A52 year old female perimenopausal patient has clear mammogram and no obvious tumor or symptom, and is diagnosed as invasive lobular carcinoma stage II 1.2x.8x.9cm at the 3 o' clock position depth of left breast by ultrasonic examination.

The device was used daily to treat the patient as a percutaneous treatment with a high intensity therapy at 2-4Hz and high output for two hours at 20cm from the left breast tumor site area during the day, and a medium output of 7.83Hz at 1-1.5 meters at night for respiratory applications. She withstands daily treatment until surgical resection after 4 weeks, during which time the change in tumor size is monitored by multiple sonications.

The results show that tumor size was reduced from 12mm to 9mm over a period of approximately 4 weeks, measured by three diagnostic ultrasound examinations, mammograms, x3 core biopsies (12 mm to 21 mm) and CT scans using the same machine and radiologist, prior to final surgical resection and subsequent final measurement and pathology results. During the trial, the tumor was reduced by about 33.3%, which shows the efficacy of this new treatment, and further changes the tumor type, from invasive "lobular" cancer to less severe "ductal" cancer.

At surgical excision four weeks, pathology reports show that the tumor is now free of cancer cells, according to all tissues tested. "no ductal carcinoma in situ" and "no lobular carcinoma in situ" are present. The lymph nodes also do not have any cancer cells. All resected edges are also devoid of any cancer cells.

It should be noted that the patient is ER+, PR+ and HER-and is considered to have a low risk and the device was selected for HER treatment regimen. The patient received a treatment regimen to see if the device would have had an effect on her tumor before she carefully decided to continue surgical resection as suggested.

After the patient finds that the side effects of radiation therapy are remaining "permanent cardiopulmonary injury", "chronic fatigue", "chest and back burns", the patient refuses to receive radiation therapy of the "standard of care" provided. If she continued radiation treatment, her 5 year survival rate was > 95% increased by only 2%, and the patient thought that the side effects would be worse than the slight increase in survival rate. She also refused hormonal treatment due to side effects.

The patient continued to use the device at night and had intermittent focal treatment (3 days per week) on both breasts with the high intensity treatment described above, for two hours each. She had regular ultrasonography of both breasts and was living normally.

Breast cancer wound research (2,288,995)

A52 year old female patient diagnosed with stage II lobular carcinoma breast cancer, had her breast cancer tumor in the left breast nipple area surgically removed. During surgery, the same surgeon also resects x3 sentinel lymph nodes from the left side of the breast near the armpit after radio-tracing for preventive analysis. The breast incisions made by the same surgeon on the same day, during the same procedure, in the same room and in the same environment are deeper than the incisions in the armpit area, but the lengths of the two are approximately the same. The patient ligates the incision over the axillary lymph node for a complete 4 week period, blocking its exposure to air species.

The patient was fully bedridden for 1 week for recovery and most of the time for the next 3 weeks. Within two days after surgery, the patient removes the bandage from the deeper breast wound and deliberately exposes it to the air species with the energy field using the arrangement described above. The device was used 22 hours at bedside every day, 1 meter distance, frequency 4Hz, medium intensity, and about 2 hours at noon every day, frequency 3-4 Hz, stronger setting, closer distance, about 20cm.

Four weeks later, the scars and color of deeper breast surgical wounds exposed to air species and energy fields were significantly lighter than those from the same procedure covered entirely with bandages.

Chronic Obstructive Pulmonary Disease (COPD)&Sleep apnea (2,288,992)

COPD and sleep apnea are studied to compare the oxygen content of subjects treated with a commercial CPAP ventilator or the above devices. The study was run for a total of 5 days, with a total usage time of 20.5 hours for the above device, and 23 hours for a commercial CPAP ventilator.

Commercial CPAP ventilators result in a 12.72% decrease in the average oxygen content in the patient's blood, while the above devices result in a 34.27% increase in the average oxygen content in the patient's blood over the same period of time. The patient states that using the device makes them feel better in the morning. This study requires further investigation of more COPD and sleep apnea patients.

New crown pneumonia (COVID-19)2,289,015)

The device is used for treating new coronaries pneumonia during the period of 1 month to 2 months in 2020.

The above apparatus is used in a 4-needle and 8-needle arrangement, with the patient lying on beds arranged on both sides of the device or around the device, without a mask in a nearly closed room, and receiving the same in the room in which they lie. The settings are different depending on the patient's O2 level and the variable assessment for each patient. About 200 patients were estimated. Two intubated patients were treated percutaneously, at a distance of 20-30cm through the center and back toward the lower part of the lung. The patient using the device is not ill and is discharged thereafter.

Diabetes foot research (2,288,994)

A severe type 2 diabetic patient gets heel pulseless (heel necrosis), which is a common bed sore or pressure sore/ulcer for advanced type 2 diabetics. In this case, the wound is so deep that the calcaneal bone can be seen through the weeping holes through the skin.

The patient resides in a nursing home using the following conventional treatment methods: cream, acid bath, bandages, conventional dressings and conventional debridement and bandages by scalpel cleaning. The patient is ready for amputation if the wound is severe and cannot be corrected. The patient also has a stent inserted into the aorta of the leg to unblock and encourage blood flow into the foot. Stents help, but are insufficient to heal the wound, which becomes more severe after 12 months of conventional treatment. Even with increased frequency of pickling and repacking, the patient's condition is still deteriorating. He refuses to amputate and requires the use of the device.

The device is placed on a wooden stool at the tail of the bed within 30cm from the patient. The first month was set to a high output of 32Hz and thereafter to 48Hz. Before using the medical device, the patient is not walking except for a toilet and a shower, and is bedridden. His diet, room temperature and environmental variables were all very stable. The patient is kept in bed until the wound is completely healed, during which time a percutaneous access is used to expose the wound to air species and energy fields. The device is most effective at a distance of 30cm from the active area. The legs were also raised slightly and placed under using a pillow and waterproof pad to collect any secretions as the wound healed. The legs are covered by an a-frame and a blanket is draped over them to prevent visitors or air conditioning bacterial air nuclei from entering the foot wounds.

Within 3 weeks, the depth of the wound closed on the bone, making it less visible, forming a scab around the edge of the wound, and stopping excessive fluid penetration. The wound width was reduced from 10cm to 3cm within 4 weeks, and slight liquid penetration was observed. The wound is not exposed to any material except that the scalpel contacts the rough scab around the wound edge to expose the frayed skin to air species and energy fields. The wound heals within a total of 11-12 weeks, allowing the patient to fully use the legs and feet. Amputation is no longer required.

Eczema case study (2,289,001)

A72 year old female patient first developed eczema on the ankle and on the inner sides of both legs, and was painful and itchy, resulting in the need for a bath in the middle of the night to deal with pain. Her doctor lets her take prednisone (prednisone), but she cannot tolerate it.

The patient was treated with the above device for two hours of intensive treatment daily, placed 30 cm from the patient's eczema, with a strong setting of 8.5-10Hz, then the setting was changed and the device was placed at the bedside for normal night use, in her case, at a medium strength of 11Hz at night and placed at a distance of 1.5 m.

After 2 days of treatment, the patient reported that the eczema feel less rough. After 8 days, the patient reported a feeling of dryness of the eczema, and the itching was further relieved. By day 14, the patient reported that she was no longer having to wash her legs at night from day 12, only had to apply moisturizer to one leg at night. By day 39, her leg color recovered to normal, pain disappeared, and itching disappeared, she had gone through normal life.

Emphysema case study (2,289,006)

A38 year old Chinese male patient diagnosed with emphysema of the lower right lung is undergoing treatment. The patient has recently stopped smoking. The front and back oximetry and peak flow meter were measured with an oximeter.

The patient performed a one month baseline measurement and the results were monitored during 12 months. The blood oxygen level averaged 98 and the peak flow averaged 584, both of which were good and stable at this time point. The following measurements were from patients with daily self-grading improvement or deterioration, using a 6-point numbering system, and comparing his afternoon (PM) results with the morning (AM) results, with the following changes in the morning and afternoon:

the fatigue feeling is improved by 54 percent.

The shortness of breath is improved by 24%.

Cough was improved by 50%.

Improved mucus secretion, 77% reduced

New crown pneumonia (Covid-19) olfactory deficit-case study (2,289,018)

A female patient with new coronatine pneumonia from romania aged 40, 65 kg received treatment with the device.

Medical diagnosis: covd 19 positive. She was uncomfortable due to low oxygen, high temperature, soft stool, very painful leg muscles, and then after stable body temperature she lost her smell. The doctor tells her to use symptomatic treatment and follow the health advice, if the condition deteriorates, please call emergency. She was prescribed meloxicam (Movalis) to treat her severe leg pain but she was intolerable. Paracetamol was used to cool her (only 3 tablets were taken). She begins to feel a strange smell without reason before she loses smell. After one week of alleviation of her covd symptoms, cough was unusually sustained for 3 weeks.

Other medical conditions: suffers from hypertrophic allergic rhinitis. Kidney stones. Heavy metal poisoning (palladium 2.5 higher than normal), right knee pain, and food intolerance.

The device was used to treat the patient at a distance of 1m from the patient, 10 hours a night. During the day, the device continued to operate for another 14 hours, but she walked in the isolated apartment, outside the two meter biological range, less than 5 meters from the device.

Within 3 days of use of the device, the symptoms of covd 19 quickly recovered. The symptoms of absence of smell then began on the day her symptom of primary covd 19 ceased and worsened further within 3 days, with complete loss of smell at day 4 after the symptoms of covd 19 subsided. After 8 days of treatment, her smell began to slowly recover. Over the next 5 days she slowly restored the full smell.

Other data collated from her daily report includes:

within 4 days after onset of symptoms, her body temperature was normal

O2 levels were not reported for the first week. After which it stabilizes normally.

By the beginning of the second week, she had 43% improvement in morning fatigue. By the end of the second week, fatigue improved by 69% in the afternoon.

On day 4, she recovered 100% of the muscle usage in the morning from severe pain, and 100% of the muscle usage in the afternoon on day 5, with no more pain occurring during these times.

Cough with symptoms of covd persisted for only two days.

After one week of cessation of the covd symptoms, her new cough continued until the end of the study (again for 14 days).

No nasal discharge. No headache. There was no change in hearing.

At week 2, her eyes were 17% painful at afternoon than am, and 14% painful at afternoon than am by week 3.

Throughout the four weeks, she urinates softly in the afternoon. Before the end of the third week, the morning is a soft stool. By the beginning of week 4, her bowel movement was normal only in the morning.

In the case of the covd symptoms, the average sleep time per night was 7.8 hours/night, increasing to 8.8 hours by week 2 when she had new cough symptoms, and then decreasing to 8.1 hours by week 4.

Fibromyalgia case study (2,289,019)

A 69 year old female fibromyalgia patient receives 15Hz medium setting therapy.

23 degrees at room temperature. Humidity 75%. The patient uses the device at his bedside.

The average blood oxygen level was 92, which was lower. The average pulse rate was 62. The morning fatigue level was improved by 43% with this device compared to without it. The brain mist using the device is improved both in the morning and in the afternoon compared to not using the device. Pain and illness was improved by 61% in the afternoon compared to the absence of the device. Pain and pain were improved by 23% in the morning as compared to the absence of the device.

Pulmonary disease-silicosis study (2,288,997)

Patients were diagnosed with silicosis in 1981 (> 40 years ago) and were treated with this device. The patient was a 78 year old female weighing 74kg. The patient does not smoke, drink wine, is rarely hospitalized, and does not work. The bicycle is ridden every day to exercise the body.

The patient is treated with the device placed 80cm to 1m from his pillow. Sleep for 8 hours/night. It is considered that it is healthy. The room temperature is 22 ℃ and the humidity is 75-80%.

Patients have heart problems, including (heart failure). There are multiple allergies, shortness of breath, sciatica problems. Hypertension (hypertension). Heart disease following 2012 stroke and heart attack. Benign paroxysmal vertigo starts from 2010 and then gastrorrhagia starts in 2017. No pacemaker.

An oximeter that measures blood oxygen and pulse rate to the patient she has the use of a peak flow meter. When reading by a patient at night, the device is placed 50cm from the patient for up to two hours and then moved to a place 1 meter away for its entire sleeping time.

The patient's bedroom humidity is higher than the average humidity so we expect this will slow down the substance somewhat into her respiratory path so the location is more important to the results. The following results were analyzed from the patient's daily report, the patient reported his/her own experiences twice a day in the morning and afternoon, and using the provided measuring tool:

The oxygen level was stable at 97 both in the morning and afternoon throughout the study.

The peak flow measured value in the morning was reduced over the first 2 weeks compared to the afternoon and then improved at weeks 3 and 4.

The fatigue level was the most severe for the week without the instrument, and then slowly improved. From week 1 to week 4, the afternoon fatigue level was improved by 45%. From week 1 to week 4, the morning fatigue level improved by 92%.

Shortness of breath, coughing and mucous secretion are all the most severe during the week when the device is not in use, and further worsen at the end of the first week. Recovery was not until weeks 3 and 4. AM: improved shortness of breath by 50%, cough by 10%, mucus secretion by 64%.

Lyme disease research (2289002)

Boehmeria lyme disease spirochete (Borelia Lyme Disease Spirochaete): slow-growing bacteria, usually caused by ticks (6-36 months before symptoms appear), have multiple system disease and multiple system failure. She was given antibiotics by her doctor. Medicament: minomycin (Minomin) 100 mg/day, natural thyroid extract 120 mg/day.

The patient was 65 year old female, weighing 64.5kg, of medium stature. It is good in diet, and does not eat cheese, egg or red meat. Non-smokers. A small amount of exercise is performed every day. Sleep for 8 hours per night. Thyroidectomy was performed in 2010 to resect goiter.

The patient has ulcers, sores and some scarring mainly on the face, back and legs. Rash known as erythema migratory. Fever, headache, itching, fatigue, which the doctor tells she to infect the internal organs.

The patient reported that it was better to use two devices at her leg and back simultaneously instead of one. The skin is improved within four weeks, the pain of lyme disease is relieved, and a considerable scar still exists. She reported that the device helped her to focus on relaxation and during this time helped her sleep better and the case study continued.

Autoimmune disease-transverse myelitis (2,289,022)

A patient with transverse myelitis is treated with the device. The patient was a 54 year old male, non-smoker. Severe transverse myelitis-spinal inflammation. Many solutions were tried, but none were the result, with the first diagnosis made 40 years ago. As a result, depression, obesity, and chronic fatigue.

The patient is unable to walk without severe back and leg pain. The leg pulls and the muscles of the back, buttocks and legs twist. If the mobility aid and/or wheelchair is not convenient, the patient is in bed most of the time. The initial setting was medium output and 32Hz, however it is clear that we first need to focus on helping to stabilize his mood so we change him to medium setting and 25Hz after the first two weeks to control his depression. We then use the position change instead of changing the settings to manage further high intensity treatments with close monitoring of him. The position varies from 20cm to 1 m.

After the first 30 days he reported a 2-5% improvement in sensation, some days being better than others. After 12 weeks he reported that "his leg pain was incredibly effective and relieved due to 15 minutes of intensive treatment (20 cm) used in the morning". After 4 weeks he had recovered his health and could try to work again, he started an office sales work after years of bed and loss. The emotion is greatly improved. We now turn attention to his nervous system because his walking ability is slowly increasing. The patient made a video of himself showing the excitement of he beginning to walk again, albeit at a slow speed and short distance. Treatment and monitoring is continued.

Autoimmune disease-2 lupus&Diabetes (2,288,990)

A44 year old female patient diagnosed with lupus and suffering from Hashimoto's disease, diabetes (type 2) and connective tissue disease was treated using the device. Does not drink wine or smoke. Low carbohydrate and low sugar diets. Patients have a variety of typical autoimmune symptoms including severe headaches beginning every morning, sustained systemic muscle pain, brain fog, extreme chronic fatigue, daily nausea, sustained rash on the face, sensitivity to sunlight. The patient claims to be sensitive to the side effects of one of his medicaments.

The patient had the device placed one meter away from bed for the first three days while she was sleeping, she had no more severe headache in the morning when she was awakened, and her blood oxygen level was elevated the next day in the morning. The patient returns the day she did not use the device, her morning regular headache. After the first few days, the patient feels more active in the morning. Muscle pain was less at the second week than before.

The measured blood oxygen level is now stable. By weeks 3-4, all symptoms were alleviated by 50% and persisted until week 7, all symptoms disappeared except for the following: 1. mild headache, once every two weeks; 2. rash was 75% less severe than the original. In all cases, the individual symptoms improved more than in the morning, except that the rash was improving slowly, based on night readings. Patient type 2 diabetes markers have now improved so at week 30 her doctor formally announced that her type 2 diabetes is resolved. She now lives normally.

Microbial growth after anion exposure (UZZAO 0018)

Nasal and upper respiratory tract swabs were taken and immersed in 1ml of sterile physiological saline, followed by vortexing for 1min. Subsequently, the bacteria-containing liquid was dispensed with a sterile inoculating loop onto 10 mueller-octanon agar (MHA) plates, 5 of which served as experimental controls, without exposure to air species and energy fields, and the other 5 plates were used for device treatment using the above-described device. There are a total of 4 noses and 6 upper respiratory tract MHA plates. A sample of the respiratory mucosa was obtained from a 19 year old female, currently suffering from upper respiratory disease, suspected of "streptococcal throat". The nasal sample was extracted from a 21 year old female, without any sign of disease.

MHC plates were grown in a controlled environment for 3 hours while the experimental group was exposed to constant airflow from the device and the control group was exposed to normal environmental airflow. During the intervention, the concentration was monitored periodically. Subsequently, the plates were incubated at 37℃in a dedicated incubator for the microorganisms. The plate was inverted to prevent coagulated droplets from falling onto the agar surface. The doctor monitors the plate every 6-12 hours for five days. Colonies present on the plates were examined, analyzed and photographed.

Several large colonies appeared on MHC plates over the course of five days. At the end of the experiment, colonies were examined and counted. The number of colonies indicates the growth rate of bacteria in the MHC plate. The average colony count on MHC plates was reduced by 72% after "three hours" exposure to air species and energy fields compared to the control group. There was also a significant difference in the number of colonies between the two groups. This is consistent with numerical results.

Three hours of exposure to the air species and energy field of the device appears to have an inhibitory effect on microbial growth of both upper respiratory and nasal colonies present on MHC plates. These preliminary findings support the results found in the experience of human subjects so far and the exploration of more studies.

Long-term viral and allergic multisystem diseases (2,289,010)

A 72 year old female suffers from a multi-system disease that stuns the female by the bite of a virus-carrying mosquito by 38 years ago, and thereafter the disease becomes increasingly severe. 85kg, non-smoker. She had a variety of allergies, weak immune systems, and severe sensitivity to EMF, food, chemicals, and weather changes. Respiratory disease, fibromyalgia, type 2 diabetes, hay fever, chronic nasal drops, and osteoarthritis.

The patient was a long-term viral patient for nearly 40 years, with settings beginning for strong allergies but less frequently at 3-4Hz. The first month was placed starting at 60 cm from each month with an additional 5 cm increase up to 1m from the patient's central pillow. The patient provided one week baseline data and observations.

After 10 days of use of the device, the patient falls asleep for the first time over the years. The oxygen level took 4 weeks to stabilize and she breathed more easily. Pollinosis disappeared by week 4, reporting more energy. Nasal drops stopped at week 9. Treatment is still in progress.

Sleep apnea&Post-traumatic stress disorder (PTSD) (2,289,013)

Men 65 years old, 8 years ago, were diagnosed with sleep apnea and were severe patients with PTSD. Has mild asthma, chronic insomnia and brain fog. Radiation therapy was received 23 years ago for leiomyosarcoma, with pericarditis and anemia. 3-5 mg of Emulan (Imovane) is taken irregularly, and 3mg of Naltrexone (Naltrexone) is taken daily.

The machine feel for patients using commercial sleep apnea therapy is poor. The patient's pulse and blood oxygenation are average and improved to normal and stable in the second week, and his fatigue level is also stable. By the third week he can sleep at 5 evenings of 7 evenings, which is the first time over many years.

The patient says that he can think more clearly and his brain mist and low-grade persistent headache have now disappeared. He perceives "stunning and sinking" when he wakes up, but the situation is improving. His mood was improved and his wife commented that he was no longer snoring.

Overview of case study

COPD and sleep apnea: oxygen improvement 34.3% (2,288,992);

sleep apnea and PTSD: all symptoms improvement (2,289,013);

respiratory pathogens: elimination 72% at the first 3 hours or use; (VZZA 00018);

pulmonary disease (silicosis): respiratory, fatigue and mucus secretion were improved at week 4 (2,288,997);

asthma: respiratory distress is improved by 48% (2,289,000);

asthma: daily cough is eliminated without taking steroids, and Chuanlening is reduced (2,288,993);

emphysema: fatigue, cough and mucus are ameliorated (2,289,006);

covd 19: a patient receiving treatment, patient condition improvement (2,289,015);

Covd 19: the loss of smell was restored on day 18 and symptoms were eliminated on day 35 (2,289,018);

glioblastoma/lung cancer advanced stage: palliative treatment improves O2, now alleviated (2,288,996);

glioblastoma advanced: palliative treatment improves relief (2,289,005);

breast cancer: tumors 5cm deep were cleared through the skin and into the margin (2,288,998);

ear basal cell carcinoma: amputation (2,288,991) is no longer required;

surgical wound: faster healing, less scarring, lighter color (2,288,995);

diabetic foot wound: amputation (2,288,994) is no longer required;

severe eczema: regression within 40 days (2,289,001);

fibromyalgia: pain and respiration were improved on day 30 (2,289,019);

phagocytes: exhibit a reaction to device materials and energy (VZZA 00015);

autoimmune disease-lyme disease: pain subsided within 30 days (2,289,002);

autoimmune disease-lupus, diabetes: most symptoms disappeared at week 7. By week 30, no type 2 diabetes markers are present (2,288,990);

autoimmune disease-transverse myelitis: leave the wheelchair, currently working (2,289,022)

Severe long-term viral and allergic combination diseases: no longer painful, pollinosis subsides, and energy persists at week 6 (2,289,010);

The above arrangement thus provides an apparatus and system for generating corona Cold Air Plasma (CAP) reactive nitrogen species (RONS) and other quantum air species having negative and/or neutral polarity by means of a pulsed electromagnetic field (PEMF) from ambient air temperature and unbalanced atmospheric pressure. In one example, the goal is to use custom designed electricity to "push" and drive air species from the device into the organism through the circuit through the quantum PEMF delivery pathwayThe way, various short-lived and long-lived reactive and non-reactive quantum air species are created, such as electrons, ions, atoms, molecules, radicals, excited states, and in this case ions of negative and neutral polarity ("air species"). This process can create a gentle ionic wind at the needle of the device, as air species come in and enter the body at high speed while rotating rapidly, they are atomically hot, but cold to the touch. When an ion charge is driven into the organism by PEMF energy, it is bound to the vibrating and rotating molecule, the resulting current causes molecular collisions in fluid channels throughout the body, vibrational resonance, and thereby produces positrons and photons which acquire energy from a cold fusion reaction inside the organism, which then produce further reactions, such as H ₂ And molecules, but these do not go beyond the organism. The currents cause the magnetic fields intersecting at right angles to interact inside and/or on the object and form an internal physiological collision environment, because repulsive and attractive pressures lead to the initiation of "vitality" (also known as dark energy/aurora/mind respiration/spirit), which we choose to name "Ruach vitality". This vitality is the same as the force field that holds the atoms within the molecule together. Inside the body of the human organism, when it generates photons and light from collisions, it energizes the biological field and fluid flow, thereby initiating the action and reaction of the molecules and systems. The novel high-speed current generated by the device can severely pull and strip electrons from molecules, so that the electrons can be immediately separated and sent back to the circuit together with other quantum energy substances such as neutropes and the like. They pass through and leave the body as an electrically conductive charge while the molecules remain in the body and are excited, and their fluids and biological fields are also excited at this time by the presence of the vital force field "Ruach".

In one example, current flows through the organism because it is forced to find a ground path to complete the circuit. The push of this electric field and the pull of the right angle magnetic field are generated from the original negative ions by CAP RONS, creating an internal Ruach force that causes bio-impact at magnetic velocity (magnetic velocity = speed of light) when the circuit energy needs to pull electrons back into the circuit. The circuit simultaneously 'pulls' the excess electrons and neutrops directly back into the device to find its ground potential, which is an accessible ground ring within the device, to complete the circuit through the common conductive ground organism and ground ring. ("energy substance")

In one example, a ground ring inside the device completes the circuit at the end after the impact by the organism. The energy substances are retrofitted with a new isolating bridge within the AC mains adapter to find the ground ring, which forces the electrons to find their way back to the ground device where they are lifted to a high potential and again ejected back into the air, creating more air species via the needle assembly. These are not observable or measurable, but we know their existence because we can see their behavior and the traces they leave.

The above device may also provide a method of using the system for an overall biological and therapeutic rebalancing solution, i.e. "therapeutic systemic selective adaptogen" ("SSA"). The application of these air and energy substances is partly by means of electroporation, plasma perforation, etc. through the human respiratory system and the skin for percutaneous absorption.

The complexity and uniqueness of this multidisciplinary scientific combination creates a new scientific technology that produces a broad range of "whole body selective adaptogen" biological activities and positive responses in organisms and blood to most healthy diseases. In this regard, the response is selective (e.g., causes apoptosis while producing an immunomodulatory response), it is systemic in that it can cross the blood-brain barrier, affect the central nervous system by retrograde nerve transport through the vagus nerve (breathing), and affect every system in the human body, with a number of mechanisms of action that are too numerous to be fully incorporated into this patent, but will become a number of patents based on this patent. Furthermore, this is an adaptive source method, a completely new combination of vitality, PEMF and air species and polarity, which means that together they help the body adapt to use its own mechanisms where it is most naturally needed, as demonstrated by the inventors' test results.

Lack of specificity of the therapeutic conditions may be suspected, but a variety of nonspecific effects are common and considered target systems for therapy that control the activity and function of organisms in many different ways that respond safely to the captured forms of air species, energy and Ruach vitality (e.g., hormones, central nervous system, immune system, etc.).

The above arrangement is applicable to the fields of global public health, medicine, biology, agriculture, materials, environmental sciences, food production, water and beverages, and the like, including similar processes for activating, purifying, preventing and treating gases, liquids and solids, and emerging scientific and technical fields including astrophysics.

Further features of the above-described apparatus will now be described.

Plasma is a unique fourth state of matter, inferior in size to solids, liquids and gases. The physical air species and waves of the plasma are minimal and are not naturally available on earth. Humans can see this "physical" plasma, known as "aurora or northern light", above the north iceberg, with a green/blue cloud in the sky; this is a visible plasma produced by the collision of charged particles, such as electrons, on a magnetic layer (100-200 klms above earth) where atoms collide with atmospheric gases in a magnetic field, resulting in the luminescence of atoms, mainly atomic oxygen (green) (as produced by this technique) or atomic and molecular nitrogen (blue and violet). CAP created these quantum air species, including reactive nitrogen oxides (RONS) and Reactive Oxygen Species (ROS).

CAP is composed of multiple components, such as electrons, ions, atoms, molecules, radicals, excited states, etc., and in this patent, the "air species" generated inside CAP are either negative or neutral in polarity. With PEMFs, these energetic electrons can effectively generate charged species, radicals, excited states, and photons within a "plasma plume" of the tip of a needle. Since the substances are small and rotate at very high speeds under non-equilibrium ambient pressure, they are accelerated by the transport route using PEMF and deliver a negative ion flux into the living body. These enable the skin and mucous membranes to be conditioned by partial etching, plasma perforation, electroporation, diffusion, activation and deposition (but not limited to these) and other of all possible methods necessary for absorption and activation of the molecules after photon generation.

These processes, together with the circuitry of the above-described device, cause collisions of generated photons, which proceed at very high speeds on the atomic scale. For example, in our example, a large number of O and O-transport photons are generated, O2 is generated in the wire pellet where it collects hydrogen and then H is generated ₂ O ₂ Or H ₂ O. Light has no mass nor charge, it has a wavelength, and in living beings its ability to do work on the planckian scale is related to the geometry of electrons that the atom itself possesses, which is the way light interacts with the body. Since it is both a wave and a particle, but without mass or charge, the geometry of the electric and magnetic fields causes the field to intersect at right angles to the field, resulting in a Fenton (Fenton) reaction.

There are many highly selective pathways that allow the human body to be stimulated to function properly. For example, substances such as NO obtain a therapeutic effect from the CAP in the correct proportion and frequency, and substances such as O obtain a killing effect from the CAP in the correct proportion and frequency. The ability of the human body to balance these effects in its own way, both adaptive and innate, means that once in the proper environment, the body has the ability to self-balance itself by introducing the proper balance of matter and energy. That is why this technique is adaptive.

With various types of CAP medical devices under development, such as DBD or Jet (N-APPJ) plasma, no other CAP medical devices worldwide function as whole body selective adaptors in all systems of the human body. Most require artificial rare gas mixtures and can only be used by doctors, because of their high efficacy and frequency, mainly in the field of wound care, dentistry and cancer. Plasma science is a multi-disciplinary field including hydrodynamic, physical, thermodynamic, atomic and molecular physics, mathematics, neuro-quantum, nanotechnology, quantum physics, chemistry, electrodynamics, electrical engineering, medicine, biology, epigenetic, neurological, just to name a few of the many disciplines involved.

RONS/ROS is a vital signaling molecule in combination with the correct current, energy and frequency and other variables that will travel to and/or affect all cells and all fluid cavities throughout the organism to perform the proper function and induce a large number of quantum phenomena, so that we need to spend the dead time to study and understand each quantum phenomenon. The mechanism of action is numerous and the result is throughout the whole body systems such as, but not limited to, enhancing phagocytic function, balancing hormones, insulin, accelerating fibroblast proliferation, etc. For example, the hydroxyl radical OH, which starts at the point of contact of the plasma species with the mucosal fluid (due to PEMF), produces peroxidation of unsaturated fatty acids of cell membrane lipids. Nitric Oxide (NO) is also a long-lived substance that is thought to regulate the immune system, collagen synthesis and keratinocyte proliferation.

Due to the pressure of modern life, contaminants in the air, water and food chains, including our excessive frequency waves in the ambient air throughout the earth's surface, we have unbalanced biological systems; this affects all humans, plants and animals, since we are all electro-organisms consisting of 70% or more water. This imbalance results in an inability to combat infections, viruses, bacteria and other pathogens, increased unhealthy and disease, and an inability to respond to good drugs and vaccines as we would. Such devices provide a safe volume and delivery mechanism for these RONS/ROS to enter the human body, central Nervous System (CNS) and blood, allowing for treatment of all systems of the body at once and over time. It improves the health of any individual who is in contact with it. People cannot take the medicine and the vaccine excessively, and the medicine and the vaccine work together with the medicine and the vaccine cannot cause injury; it provides a solution for drugs and vaccines to perform their intended function for people of all ages and conditions.

The above-described device can generate a cold air plasma in front of negative ions, where short-lived and long-lived RONS/ROS and other quantum air species are generated in the cold air plasma plume and are biologically active up to two meters (not just 2-5mm according to the existing CAP industry), where the benefits of long-lived species are generally only observed.

The above device can generate corona CAP from ambient air and does not require a gas tank to drive its air energy. It uses negative and neutral polarities and no others.

The device described above allows to combine extremely weak frequencies with PEMFs, weak CAPs and strong magnetic circuits forming weak currents to obtain reproducible biological results, since the metabolism of all biological organisms is accompanied by charge transport and known redox and photosynthesis processes.

Inside the human body, the pulling of the pushed PEMF and circuit ground ring creates a cross-collision, where a magnetic field is created at right angles to promote the formation of Ruach viability that affects the body's fluids, biofield and bioelectric currents, as the photons it creates cause molecular reactions and combined currents to remove electrons from the molecules, leaving the molecules behind, by the special isolation bridge design of the AC adapter, causing the electrons to return to the circuit and back into the ground ring inside the device.

PEMFs consist of various waves including, but not limited to, electrostatic, carrier, fourier and frequency tone (acoustic) matching and substance correction waves to maintain the spin and momentum of the air-mucus exchange towards the person "within a tailored delivery pathway," which, in part, together with Ruach viability, create resonance effects in fluids, biological fields and cellular structures throughout the human body, resulting in successful cellular communication. Because these fields are weak, this effect is strong.

In one example, the bridge resistor of the AC adapter allows a return path for the quantum substances and energy that allows the grounded human body to be pulled into the center of the circuit, so the substances flying from the device back to the device travel at magnetic speed, and the push-pull mechanism with the human body helps the smallest and fastest quantum substances and the energy produced to be bioactive in all human systems.

The resulting current causes a stripping effect that removes excess electrons from the molecule, returns the electrons to the device's ground ring for its energy return path in the circuit, while the charged, reacted and excited molecules do not move outside the body.

The quantum and CAP substances associated with PEMFs can induce vibrational resonance within the respiratory system, resulting in simultaneous retrograde transport of air species and energy substances along the oronasal vagus nerve in the upper respiratory system, thereby allowing for the passage through the blood-brain barrier, producing sustained systemic effects throughout the body from the then-current Central Nervous System (CNS), which coordinates its own natural, adaptive and innate immune responses, balancing the effects of CAP in a selective, systemic and adaptive manner.

Human cells and body fluids can communicate by acoustic resonance. The life of a cell is controlled by its energy frequencies, which specify the language and its physical environment, and not by its genes, whose knowledge initiates the life-driving mechanism of action. Such devices control the energy language and physical environment to allow the cells to react in the desired manner and thus the genetics of the organism to operate in the manner they should.

In this specifically designed safety combination, the body can absorb and respond to the air species, PEMF and Ruach vitality generated throughout all the body's systems, with various benefits, such as but not limited to the nervous system, immune system, respiratory system, cardiovascular system, etc., and assist in pharmacy and vaccines by making this technology and science "whole body selective adaptors".

The above-described device thus works by generating corona, cold air, plasma, RONS and other quantum air species at the tip of the needle of the apparatus. PEMFs and other quantum physical waves and transmission pathways are established with selectable outputs and frequencies. Cold air plasma species having a negative polarity and/or a neutral polarity are transferred to the body of the subject by way of a ground return path incorporating circuitry of the device. Muons and neutrinos leave the body from the pulling magnetic effect into the latter half of the circuit, and when electrons are stripped from molecules in the body, photon light (which is a field of life called Ruach energy) is generated in the body and returned to the device. This causes a systemic selective adaptive response to the human body, resulting in the medical benefits described above.

Throughout the above, the term "subject" may include a living subject, such as a human, animal, or plant.

Throughout the specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or group of integers or steps but not the exclusion of any other integer or group of integers. As used herein, the term "about" refers to ± 20% unless otherwise indicated.

Those skilled in the art will recognize that many variations and modifications will be apparent. All such variations and modifications which become apparent to those skilled in the art are deemed to fall within the spirit and scope of the utility model as hereinbefore described.

Claims

1. An apparatus for generating a cold air plasma, the apparatus comprising:

a) A housing including a plurality of spaced apart openings;

b) A plurality of needles, each needle positioned in a respective opening;

c) A drive circuit that generates an electrical signal that is applied to the needle to generate a pulsed electromagnetic field, wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency to generate a cold air plasma.

2. The apparatus of claim 1, wherein the electrical signal and the pulsed electromagnetic field have varying frequencies, intensities, and a plurality of waveforms, the plurality of waveforms comprising at least one of:

a) A non-square waveform;

b) A right-angle waveform;

c) Square wave shape;

d) A sinusoidal waveform;

e) A triangular waveform;

f) A composite waveform;

g) Fourier modifying the waveform;

h) A zigzag waveform;

i) Wave grain bistrunk; the method comprises the steps of,

j) Shark tooth waveform.

3. The device of claim 1, wherein the carrier frequency is at least one of:

a) In the range of 17kHz to 18 kHz;

b) In the range of 17.25kHz to 17.75 kHz;

c) In the range of 17.4kHz to 17.6 kHz; and

d) About 17.5kHz ± 0.25%.

4. The apparatus of claim 1, wherein the pulse frequency is at least one of:

a) In the range of 0.1Hz to 40 Hz;

b) In the range of 0.1Hz to 4Hz;

c) Less than 1Hz;

d) About 4Hz;

e) About 7.83Hz;

f) About 8Hz;

g) About 10Hz;

h) About 16Hz;

i) About 25Hz;

j) About 32Hz; and

k) About 40Hz.

5. The device of claim 1, wherein the device comprises a user input allowing selection of pulse frequency and intensity.

6. The apparatus of claim 1, wherein the drive circuit comprises:

a) A rectifier configured to be attachable to a mains power supply;

b) A switch mode power supply coupled to the rectifier;

c) A pulse transformer coupled to the switched mode power supply; and

d) A voltage multiplier connecting the pulse transformer to the pin.

7. The apparatus of claim 6, wherein the pulse transformer is one of:

a) Configured to produce an output voltage of approximately 3500-4500 volts; and

b) Comprising 178: a turns ratio of 1.

8. The apparatus of claim 6, wherein the voltage multiplier is configured to produce an output voltage of about 17500 volts.

9. The apparatus of claim 6, wherein the electrical signal at the tip of the needle has a voltage that meets at least one of the following conditions:

a) Greater than 12000 volts;

b) In the range of 12000 volts to 14000 volts;

c) In the range 12500 volts to 13500 volts; and

d) About 13000 volts ± 0.25%.

10. The apparatus of claim 6, wherein the power circuit comprises a bridge resistor arrangement bridging the AC adapter transformer.

11. The apparatus of claim 10, wherein the bridge resistor arrangement provides a ground reference via a neutral line of an ac mains power supply.

12. The apparatus of claim 10, wherein the bridge resistor arrangement comprises at least two resistors providing two operator protection devices and a return path for charged electrons from the circuit.

13. The apparatus of claim 1, wherein the apparatus is configured to provide a return current path, allowing electrons stripped from molecules and/or ions to return via a treatment object.

14. The apparatus of claim 1, wherein the apparatus comprises an insulating member surrounding the high voltage component.

15. The apparatus of claim 14, wherein the insulating member has at least one of the following features:

a) Has a curled shape; and

b) Providing a current flow path to the needle.

16. The device of claim 1, wherein the device comprises an ac adapter configured to be attachable to an alternating mains power supply.

17. The apparatus of claim 16, wherein the ac adapter comprises a barrel plug connected to a barrel socket in the housing, and wherein the barrel socket is recessed into the housing to reduce static electricity accumulation.

18. The apparatus of claim 16, wherein the ac adapter comprises a pulse transformer.

19. The apparatus of claim 1, wherein the apparatus is configured to be capable of generating corona cold air plasma and quantum air species having a negative or neutral polarity at and/or within a plasma plume at a tip of the needle or in a plume space just beyond the tip of the needle of less than about 3 mm.

20. The apparatus of claim 1, wherein the apparatus comprises a plurality of gold plated needle assemblies in electrical contact with the voltage multiplier, each needle assembly configured to receive a respective needle.

21. The apparatus of claim 1, wherein the needle comprises:

a) A shaft configured to be attachable to a needle assembly within the housing; and

b) A tip protruding into an opening, the opening being a hollow semicircular opening.

22. The apparatus of claim 21, wherein the length of the shaft is about 60% of the length of the needle.

23. The apparatus of claim 1, wherein the needle is made from a combination of multiple metals.

24. The apparatus of claim 1, wherein the apparatus comprises up to eight needles circumferentially spaced around the circular housing, and wherein every fourth set of needles are equally spaced from each other.

25. The device of claim 1, wherein the device comprises one or more caps configured to be positioned in the opening to selectively deactivate the one or more needles.

26. The device of claim 1, wherein the device is configured to be capable of and/or cause the generation of at least one of:

a) RONS and/or their inverse;

b) A complex mixture of RONS and/or their inverse particles;

c) ROS and/or counter-particles thereof;

d) Singlet oxygen, superoxide and/or their related and counter particles;

e) Electrons, positrons, atoms, and photons;

f) Muons, pi-muons, protons, anti-protons, neutropes, anti-neutropes, wavelets, neutral quantum elements and quantum particles;

g) Force field energy quantum particles and waves;

h) Ruach energy;

i) Ruach vitality;

j) Dark energy;

k) A counter substance;

l) quantum air species and quantum energy fields;

m) redox effects on and in the body; the method comprises the steps of,

n) electroporation and/or plasma electroporation on skin.

27. The apparatus of claim 1, wherein the apparatus is configured to generate a cold air species having at least one of the following ion densities:

a) Over 900000 ions per cubic centimeter at one meter from the apparatus;

b) Over 990 tens of thousands of ions per cubic centimeter at 300mm from the apparatus;

c) Over 2800 tens of thousands of ions per cubic centimeter at 100mm from the apparatus; the method comprises the steps of,

d) At 50mm from the apparatus, more than 3000 tens of thousands of ions per cubic centimeter.

28. The apparatus of claim 1, wherein the apparatus is configured to generate cold air species having an ozone concentration of less than 0.04 ppm.

29. The apparatus of claim 1, wherein the apparatus is configured to be capable of generating air species having at least one of the following flow rates:

a) Over 40.3 trillion ions per second at 300mm from the apparatus;

b) Over 50.1 trillion ions per second at 100mm from the instrument; the method comprises the steps of,

c) At 50mm from the instrument, over 76.8 trillion ions per second.

30. The device of claim 1, wherein the device is configured to enable at least one of:

a) Generating a pulsed electromagnetic field;

b) Generating ions in air adjacent to the housing;

c) Generating into the air in the vicinity of the housing various air species including electrons and ions at a high spin atomic temperature but which are cold to contact;

d) Generating various wave grain biennial air species including electrons and ions;

e) Transporting ions away from the housing;

f) Delivering various air species including electrons and ions into the air delivery pathway exiting the housing and into or onto the human body;

g) Creating an environment in which the pulsed electromagnetic field collides with the magnetic field at right angles to generate cold fusion discharge and light energy photons within the body;

h) Changing the field by collision of the circuit such that the field is directed again perpendicular to the second direction of the device;

i) Generating a biosafety discharge from cold fusion and generating photons of light energy, muons and pi-muons in the body;

j) Generating biosafety electrical discharge and photon energy inside the body, resulting in water electrolysis occurring, generating H in the body's chemical components ₂ ；

k) Leaving the charged molecules in the body while the current and magnetic flow strip electrons and/or mesogens from the molecules and then out of the body;

l) leaving the charged molecule in the body, while electrons and neutropes quantum tunneled out of the body, out of the molecule and back into the circuit;

m) pulling various air species including electrons and/or neutrinos back into the circuit and then to ground established within the housing;

n) pulling electrons to ground and back into the device, wherein the electrons return to the needle and become secondary electrons that preserve their previous energy memory, such that the secondary electrons are more energetic than before being placed back into the treatment object; the method comprises the steps of,

o) the process is repeated through the circuit at a magnetic speed approaching the speed of light.

31. The device of claim 1, wherein the device is configured to be able to provide selective whole body adaptogen therapy to the subject and responses from the subject's body and/or create an environment for dynamic balancing to occur within the subject.

32. The apparatus of claim 1, wherein the cold air gas plasma produces RONS and/or other air species capable of transferring reactivity into the fluid of the respiratory mucosal system to induce further biochemical reactions and pathogen inactivation by intracellular and intercellular water-memorized plasma and biological field communication.

33. The apparatus of claim 1, wherein the conductivity in the subject is determined by negative oxygen containing ions and not by electrons, which are stripped from the ions leaving molecules within the subject while the electrons return to the circuit to obtain ground potential.

34. The device of claim 1, wherein the device is configured to drive air species and pulsed electromagnetic fields and resonances into the respiratory system and/or skin and/or orifices of a subject at least in part through a common ground connection with the subject.

35. The device of claim 1, wherein the device is configured to create a balanced and steady-state environment by a combination of CAP, RONS, pulsed electromagnetic field, and energy vitality to restore molecular aging and cytoetiology.

36. An apparatus for generating a corona cold air plasma, the apparatus comprising:

a) A housing including a plurality of spaced apart openings;

b) A plurality of needles, each needle positioned in a respective opening;

c) A drive circuit that generates an electrical signal applied to the needle to generate a pulsed electromagnetic field, wherein the electrical signal alternates at a carrier frequency and modulates at a pulse frequency to generate a corona cold air plasma RONS and quantum species of negative and neutral polarity excited by Ruach viability, and wherein the apparatus induces a whole body selective adaptive primary reaction within the treatment subject when the treatment subject is exposed to the generated corona cold air plasma.

37. The apparatus of claim 36, wherein the whole-body selective adaptive response is generated by Ruach life force field energy and its subsequent use in generating H ₂ Is induced and excited by water electrolysis.